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Preface 
My background is in nursing and is diverse, and includes experiences in somatic 
hospital care, home care, nursing home care and psychiatry. My introduction to the 
world of porphyrias began after I finished my master thesis in genetic counselling 
(GC) at the University of Bergen in 2007. I was then employed, and have since 
worked, as a genetic counsellor at the Norwegian Porphyria Centre (NAPOS). When I 
started working at NAPOS, I had barely heard of porphyria and I wondered how my 
master research could be helpful in understanding the challenges met by persons with 
porphyria and help me in the GC of this patient group. My master thesis was published 
as an article about living with an increased risk of sudden cardiac death because of 
long QT syndrome (LQTS) (1), a genetic condition in which the first symptom of 
disease can be sudden cardiac arrest. 
Although the symptoms are very different, I quickly came to see several similarities 
between the acute porphyrias and LQTS. Both conditions are hereditary and follow an 
autosomal dominant pattern that is low in penetrance and has variable expressivity. 
These conditions are rare, their symptoms are easily mistaken or confused with other 
health complaints, certain medications should be avoided, and they can be fatal in 
some cases. Predictive testing can be beneficial because the conditions are rare and are 
often not recognized by health professionals. The acute porphyrias and LQTS are 
some of the few diseases that are tested predictively in children in Norway. Both 
conditions can be avoided through lifestyle advice and preventive measures, but there 
are no black and white solutions, and prevention of disease cannot be guaranteed. 
These factors mean that these conditions pose special challenges in terms of GC, 
treatment and general follow-up of patients. The low penetrance and the ambiguity of 
symptoms can contribute to the potential for medicalization and assuming that 
everyday health complaints as more serious than they are. At the same time, these 
conditions should not be underestimated. Although rarely serious, the acute porphyrias 
can be lethal, and extra caution is needed when counselling this group of patients. 
I became curious about the subjective experiences of persons with porphyria cutanea 
tarda (PCT). Surprisingly, considering that PCT is the most common form of 
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porphyria, hardly any research had focused on the patient perspective. Although PCT 
as a condition is considered undramatic, to have a good prognosis, to be easily treated 
and, for many, to have lifelong remission, this condition is visible and many patients 
experience long diagnostic delays. Through my work with PCT patients and their 
asymptomatic relatives, I formed the impression that PCT is not always as 
unproblematic as assumed. 
Research activity is highly encouraged at NAPOS, although I was not accustomed to 
this as a nurse. Most of the research being performed at NAPOS was in the laboratory 
setting and there is a strong positivist research culture. Coming from a different 
background, I was interested in the subjective aspects of the porphyrias. This meeting 
of different research paradigms has influenced the design and choices made in 
completing this PhD project. However, I believe that taking a “mixed position” has 
been rewarding in that it has allowed for a broader understanding of the challenges 
facing people with acute intermittent porphyria and PCT, and has provided empirical 
findings that complement and elaborate each other. Hopefully the results are of interest 
and clinical value for both porphyria patients and their caregivers. 
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Summary 
Background: To optimize patient care, follow-up and genetic counselling of persons 
with acute intermittent porphyria (AIP) and porphyria cutanea tarda (PCT), 
investigations into the subjective experiences of persons living with these conditions 
are warranted. 
Aims: The overall objective of this thesis was to investigate the psychosocial and 
health-related challenges faced by people with AIP and PCT. The specific aims were: 
1) to investigate the subjective experiences of adolescents and young adults who were 
genetically tested for AIP as minors and to identify the psychosocial consequences and 
how they are handled; 2) to explore the experiences of persons with PCT concerning 
their symptoms, treatment, prevention and follow-up; 3) to describe and compare 
illness perception, self-reported health complaints and psychological distress in 
persons with various activity of PCT and 4) to examine the associations between 
illness perception, self-reported health complaints, PCT symptoms and psychological 
distress. 
Material and methods: In this thesis we used a multi-methods approach. Individual 
interviews were performed with 10 persons who had received a positive predictive 
genetic test result for AIP as minors. Three focus groups with a total of 21 persons 
with experience of the symptoms of PCT were carried out. The last part of the study 
was cross-sectional and included a questionnaire completed by 263 subjects who had 
PCT with active symptoms, were in a remission phase, or were an asymptomatic 
mutation carrier. 
Results: Young persons tested genetically for AIP described few psychosocial 
challenges but found it difficult to become motivated to make lifestyle modifications. 
For some, the thought of developing an active disease was a cause for concern. AIP 
was experienced as a vague condition, and participants and their families attributed a 
range of health complaints to porphyria. 
PCT was perceived as a chronic and systemic condition, and participants described a 
shift in their focus from skin to blood. Health complaints other than skin symptoms 
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were attributed to PCT. Symptoms varied greatly and, at their worst, were dramatic 
and described as “living in a horror movie”. 
Participants with active PCT reported higher perceived illness threat, more subjective 
health complaints and higher degrees of psychological distress compared to 
asymptomatic participants.  Psychological distress about PCT was however associated 
with perceptions of illness and total health complaints but not with PCT symptom 
activity. 
Conclusions and implications: The results from this study show that symptoms of 
PCT can be dramatic and should be addressed, but asymptomatic phases can also be 
problematic. Separating the symptoms of AIP and PCT can be difficult for patients, 
and a clearer definition of an AIP attack and PCT symptoms would be beneficial. 
When in a phase of active disease, it is important that patients know how to implement 
and increase their treatment compliance while also avoiding medicalization of persons 
in remission or at risk of developing AIP or PCT. Patients’ perceptions of the 
condition should be considered, and appropriate follow-up, counselling and 
reassurance during clinical consultations are recommended.  
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This thesis was designed to address the lack of formal and scientifically based 
knowledge about the subjective experiences of persons with acute intermittent 
porphyria (AIP) and porphyria cutanea tarda (PCT). AIP and PCT are the most 
common forms of porphyria (2), and more than 90% of the patients registered at the 
Norwegian Porphyria Centre (NAPOS) have one form. The aim of NAPOS is to 
improve the diagnostics, treatment and follow-up of patients with porphyria (3). Both 
AIP and PCT are diseases that, for most patients, involve large periods of remission 
while at the same time requiring monitoring and follow-up to prevent relapses. Some 
people are genetically predisposed but have never experienced symptoms, and 
appropriate knowledge is essential for predictive genetic testing to be beneficial to 
them. Because AIP and PCT affect people both when symptomatic and asymptomatic, 
it is important to understand how the symptomatic and asymptomatic phases of AIP 
and PCT are experienced by patients. Further investigations into the experiences of 
living with porphyria have also been recommended by patients (4) Consequently, we 
wanted to investigate the patients’ perspectives on AIP and PCT, and to generate 
pragmatic and relevant knowledge that could be applied to both genetic counselling 
(GC) and nursing. 
The following section starts with a general introduction of the porphyrias and is 
followed by a more specific presentation of PCT and AIP, an introduction to NAPOS 
and the centre’s main tasks and objectives, and GC practice in Norway and at NAPOS 
in particular. The theoretical framework behind the patient-reported outcome (PRO) 
measures reported in paper III and the backdrop for the discussions are presented. The 
empirical findings and the methods used to obtain these findings are discussed, and the 
future perspectives and clinical implications are formulated. 
1.2 Porphyria 
Porphyria is a common denomination for a group of rare and mainly inherited 
metabolic diseases. Each porphyria is caused by abnormal function of different 
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enzymes in different steps in the haem synthetic pathway, which cause accumulation 
of specific porphyrins and porphyrin precursors and different symptoms (2). Seven of 
the porphyrias are caused by a reduced activity in the haem synthetic pathway, and the 
most recently described type of porphyria is caused by a gain-of-function mechanism. 
The porphyrias are generally classified into acute and cutaneous types. Acute 
porphyrias can cause attacks that typically present as abdominal pain and can be life 
threatening. The cutaneous porphyrias present as photosensitivity and can cause pain 
or skin fragility and blisters. Some of the porphyrias involve a combination of the two 
and may cause acute attacks while also causing cutaneous manifestations. 
The porphyrias can also be defined as either hepatic or erythropoietic, depending on 
which organ the accumulation of metabolites occurs (2). The seven variants of 
porphyria in Norway are AIP, hereditary coproporphyria, variegate porphyria, PCT, 
erythropoietic protoporphyria (EPP), congenital erythropoietic porphyria and 
hepatoerythropoietic porphyria. A new porphyria, X-linked dominant protoporphyria 
(XLDPP) was reported in 2008. XLDPP presents with an identical phenotype as EPP 
but is caused by a gain-of-function mutation in the ALAS2 gene. The rate of 
transmission of XLDPP to subsequent generations is larger than in EPP, but there is an 
absence of father-to-son transmission (5). The present thesis focuses on the two most 
common forms of porphyria in Norway, AIP and PCT. The prevalence of symptomatic 
disease in Norway is estimated at 10 per 100,000 population for PCT and 4 per 
100,000 population for AIP (6). 
1.3 Acute intermittent porphyria 
AIP presents as acute attacks of abdominal pain, nausea and/or vomiting, headache, 
muscle ache, muscle weakness, paresis and mild psychological symptoms. Symptoms 
are typically triggered by a range of common medications, hormones, alcohol, stress 
and fasting or low-caloric intake. Often, a combination of triggering factors is needed 
for symptoms to develop. AIP has a variable expressivity, which ranges from few and 
mild attacks to frequent and serious attacks requiring hospital admittance. Serious 
paralysis and respiratory failure are potentially lethal complications in AIP attacks (2, 
7, 8). Treatment consists of avoiding precipitating factors, adequate nutrition, and in 
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severe attacks treatment with heme arginate. Liver transplantation is a curative but 
high-risk option for patients suffering severe recurrent attacks (9). 
The incidence of symptomatic AIP in Europe is calculated to 0.13 per million per year, 
except for Sweden, where the numbers are higher (0.51) probably because of a founder 
mutation. The estimated percentage of AIP patients who will develop recurrent AIP 
attacks is 3–5%, when recurrent attacks are generally defined as four or more attacks 
per year. The number of mutation carriers developing symptoms seems to be 
decreasing, possibly because of improved management (10). Diagnosis of 
symptomatic AIP is based on detecting increased urinary porphobilinogen (PBG) and 
5-aminolevulinic acid (ALA) concentrations in urine and further analysis of 
porphyrins in urine, faeces and blood (11). There are also indications that the majority 
of AIP patients in remission have increased PBG and ALA concentrations (12, p 34-
35). 
AIP is inherited in an autosomal manner and, as a consequence, any first-degree 
relative of a person with an AIP mutation has a 50% risk of having inherited the same 
mutation in the hydroxymethylbilane synthase (HMBS) gene. The condition has low 
penetrance, and 20–30% of mutation carriers develop symptoms, which present with 
varying degrees of severity (13). Because of hormonal factors, attacks occur rarely 
before puberty, are more common in women than in men, commonly peak in 
occurrence within the third decade, and occur rarely after menopause. Most 
individuals with symptomatic AIP have one or a few attacks during their lifetime and 
full recovery for the rest of their lives (2). Manifest AIP refers to the occurrence of one 
or more AIP attacks throughout life, and latent AIP refers to the disease identified by 
predictive genetic testing in a person with a genetic disposition for porphyria but 
without having had any symptoms. AIP thus exists in a manifest and latent form. 
NAPOS offers GC and predictive genetic testing to at-risk relatives of persons with a 
known AIP mutation. 
1.4 Porphyria cutanea tarda 
PCT is the most common form of porphyria worldwide (2) and is characterized by 
fragile, vulnerable skin and blisters on sun-exposed areas. It exists in both a hereditary 
19 
and a non-hereditary form. Both variants are triggered by factors such as high ferritin 
levels, high alcohol intake, oestrogens and various liver diseases. Onset of the disease 
is most common in late adulthood, and the median age for symptom debut in Norway 
is 54 years (6). PCT is characterized by elevated concentrations of uroporphyrins and 
heptaporphyrins in urine. Diagnosis is based on analysis of porphyrins in urine, faeces 
and blood in order to differentiate between the different porphyrias that can cause 
bullous symptoms (12, p 45-47). The established diagnostic criteria are described in 
the literature (11). 
Treatment comprises phlebotomy to reduce hepatic iron stores and/or by administering 
chloroquine to increase excretion of porphyrin metabolites in urine. Treatment is 
usually prolonged and may require up to 15 months before clinical and biochemical 
remission is achieved (14, 15). Many PCT patients will remain in lifelong remission, 
although some will need to repeat treatment after a few years. Familial PCT (fPCT) is 
inherited in an autosomal dominant pattern, with a low penetrance of about 10% (16). 
At NAPOS, everybody diagnosed with clinically active PCT will be investigated for a 
mutation in the gene coding uroporphyrinogen decarboxylase (UROD) to determine 
whether they have sporadic PCT (sPCT) or fPCT. NAPOS offers GC and predictive 
genetic testing to family members older than 16 years who are at risk of PCT. 
1.5 Norwegian Porphyria Centre 
NAPOS was initiated by the Norwegian Ministry of Health and Care Services in 1999 
and is situated at the Laboratory for Clinical Biochemistry at Haukeland University 
Hospital in Bergen. NAPOS is incorporated into the Norwegian National Advisory 
Unit on Rare Disorders (NKSD), whose main task is to ensure that people with rare 
disorders receive holistic and individually based care that cannot be expected to be 
provided for within the main public health-care system (17). NKSD comprises eight 
national Centres of Expertise on Rare Disorders, each of which is responsible for 
specific disorders, where patients, their families and professionals can seek help and 
advice. 
The main objective of NAPOS is to establish better quality of services by improving 
and optimizing diagnostics, treatment and follow-up of all persons with porphyria in 
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Norway. NAPOS diagnoses almost all porphyria patients in Norway and has started 
the Norwegian Porphyria Registry (NPR) for this patient group. When a person is 
diagnosed with AIP or PCT, NAPOS issues an identification card for the person to use 
when seeking health-care services, which helps to avoid potential use of 
porphyrinogenic medications (acute porphyrias) and to ensure that appropriate 
treatment is initiated. NAPOS devotes considerable work to providing annual courses 
for patients and health personnel, updated webpages (www.napos.no) and the 
distribution of information letters. Research to gather relevant information is critical to 
the centre, and NAPOS has an active research environment with extensive 
international contacts that include basic, epidemiological and pharmaceutical research. 
A range of research is initiated by the centre, and several PhD candidates and master 
students are affiliated with NAPOS. NAPOS also administers the NPR and the 
European Porphyria Registry (EPR). The centre started a database that contains an 
overview of porphyrinogenic medications in 2003; the English version was launched 
in 2005 and is used worldwide (www.drugs-porphyria.org). 
By the end of 2014, NAPOS had registered 344 persons with AIP and 690 persons 
with PCT (table 1). During 2014, 56 newly diagnosed persons with PCT and nine with 
AIP were registered (3). At the start of the present project, the corresponding number 
of registrants was 313 with AIP and 529 with PCT (18). 
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Table 1: Total number of patients registered at NAPOS 2014 
Diagnosis  
Porphyria cutanea tarda (PCT) 690






Variegate porphyria (VP) 34







Total - all diagnoses 1127
1.6 Psychosocial aspects of AIP and PCT 
Only a modest amount of research has focused on patients’ experiences of AIP and 
PCT, and how the disease affects their daily life. A qualitative study of five women 
from Sweden concluded that AIP attacks caused the deepest despair, which included 
extreme pain both physically and mentally (19). Others have shown that AIP is 
associated with a lower quality of life (QoL) when compared with other acute 
porphyrias, and that for many patients, AIP has lifestyle consequences such as reduced 
work capacity and family size, in particular in those with manifest AIP. Depression 
and anxiety were more prominent in persons with AIP compared with the normal 
population (20, 21). A 2009 Swedish study found that one-fifth of those with manifest 
AIP received a disability pension (22). These findings indicates that AIP can have 
large psychosocial consequences for those afflicted and that growing up in a family 
with a member with AIP might affect relatives in a serious way. These findings also 
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emphasize the need for greater understanding of the psychosocial aspects of manifest 
AIP and the effects of living with the risk of AIP, as is the case in latent AIP. 
Skin disease in general is associated with psychosocial and psychiatric morbidity and, 
although the direction of this association is unclear, should be taken seriously because 
of the association between skin disease and emotional suffering, poor adherence to 
dermatological treatment and impaired QoL (23). Photodermatoses are associated with 
psychological impact, distress and lifestyle impact (24-27), and the impact of 
blistering dermatoses poses a significant burden on QoL associated with shame and 
poor hygiene (28). 
Although PCT is the most common form of porphyria worldwide (2), little has been 
published on the psychosocial aspects of this condition. A British questionnaire survey 
examined QoL in 790 persons with photodermatosis, including 12 with PCT. Although 
most PCT participants were probably in clinical and biochemical remission at the time 
of the survey and thus the results should be interpreted with caution, the authors 
concluded that PCT had a much smaller effect on QoL than other conditions such as 
EPP (29). As of August 2009, the NPR had information about 314 persons with active 
PCT or PCT in remission. When asked whether PCT had any impact on their QoL, 
45% (n = 142) answered that PCT had a moderate to great influence on their QoL 
(unpublished data). We therefore felt that further information about the psychosocial 
and health-related challenges faced by people with PCT was needed for NAPOS and 
other health-care providers to optimize the care and follow-up of this patient group. 
1.7 Genetic testing 
Norwegian legislation defines various subtypes of genetic testing and provides the 
following distinctions: 
a) genetic testing to diagnose disease 
b) presymptomatic genetic testing, predictive genetic testing and testing to 
determine whether or not a person is a carrier of hereditary disease that will 
only be expressed in later generations (carrier testing) 
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c) laboratory genetic testing to determine sex, with the exception of laboratory 
genetic testing for identification purposes (30)
When presymptomatic, predictive or carrier genetic testing is performed, the law states 
that, “genetic counselling shall be given before, during and after testing” (30§5-5). 
The Norwegian Biotechnology Act, 2003, §5-7 also states that predictive genetic 
investigations shall not be performed on persons younger than the age of 16 years, 
“unless the test can detect a condition for which treatment may prevent or reduce 
damage to the child’s health”. In such cases, “the child’s parents or another person 
who has parental responsibility shall also be given genetic counselling” (30§5-5). 
Before predictive genetic testing is performed, “the person being tested must provide 
written consent to the test. If the person being tested is a child under the age of 16, 
written consent must be provided from the child’s parents or others with parental 
responsibility” (30§5-4).
This is also in line with European ethical guidelines for predictive genetic testing of 
minors (31-33). 
NAPOS routinely performs genetic testing of persons with a biochemical diagnosis of 
porphyria. Sequencing of the UROD gene is performed in patients with a clinically and 
biochemically confirmed PCT diagnosis. Predictive genetic testing is offered to family 
members of patients with a UROD mutation but predictive testing is performed only in 
persons older than 16 years. 
For AIP, predictive genetic testing is offered to family members of persons with a 
confirmed diagnosis and a detected pathogenic mutation in the HMBS gene. 
Symptoms of AIP are rarely seen before puberty, but a few documented cases have 
been reported (34-37). A predictive genetic test for AIP is expected to ensure a better 
prognosis for a child through avoiding precipitating factors and providing rapid 
diagnosis and treatment should an attack occur (38). On this basis, NAPOS offers 
predictive genetic testing to minors, but this is required to be accompanied by GC and 
written consent from the legal guardians. NAPOS does not consider very early testing 
as a medical necessity, and it is up to the parents of the child to decide what age is 
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appropriate. It is thus important to understand more completely how predictive genetic 
testing for AIP in minors might affect their psychosocial life.
1.8 Genetic counselling 
In this thesis, as in professional work as a genetic counsellor at NAPOS, the definition 
of term GC is that of the American Society of Human Genetics Ad Hoc Committee on 
Genetic Counseling. 
GC is defined as: 
“…a communication process which deals with the human problems associated with 
the occurrence, or the risk of occurrence, of a genetic disorder in a family. This 
process involves an attempt by one or more appropriately trained persons to help the 
individual or family (1) comprehend the medical facts, including the diagnosis, the 
probable course of the disorder, and the available management; (2) appreciate the 
way heredity contributes to the disorder, and the risk of recurrence in specified 
relatives; (3) understand the options for dealing with the risk of recurrence; (4) 
choose the course of action which seems appropriate to them in view of their and their 
family goals and act in accordance with that decision; and (5) make the best possible 
adjustment to the disorder in an affected family member and/or to the risk of 
recurrence of that disorder” (39, p 673). 
This is consistent with the view that GC is appropriate for predictive testing and for 
the long-term management of a disease. For NAPOS to achieve its aim of providing a 
better quality of services through improving and optimizing diagnostics, treatment and 
follow-up of all persons with porphyria in Norway, information and knowledge about 
the hereditary mechanisms involved are important for helping patients manage their 
disease. Also sPCT patients in remission or with symptomatic disease may need 
guidance and counselling about living with the disease and preventing future relapses. 
This implies that, to provide appropriate GC to porphyria patients, health-care 
providers need greater knowledge about the psychosocial and health-related challenges 
faced by patients. 
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THEORETICAL FRAMEWORK 
In paper III, the instruments Brief Illness Perception Questionnaire (BIPQ) and the 
Impact of Events Scale (IES) were used to investigate the constructs of illness 
perception and psychological distress, and the theories behind the development of 
these two instruments are presented. The BIPQ is based on the Common-Sense Model 
of illness perception (CSM) (40). The IES was developed from the theory of the stress 
response by Horowitz and colleagues (41). A short introduction to the biopsychosocial 
model (BPS) of health (42) is presented as background for the discussion and 
underlying perspective of health and illness used in this thesis. 
2.1 Biopsychosocial model 
The biomedical model (BM) of illness, also referred to as the “disease model” or 
“medical model”, is based on the idea that there is a clear and direct causal relationship 
between a disease and its signs and symptoms (43). A “Cartesian” split between the 
mind and body has led to a restricted pathology model of disease that excludes social 
and psychological issues from the traditional disease model. The BM is relevant to 
acute illness or exacerbation of a chronic condition, but it does not provide a satisfying 
explanation of the complexity of health and illness, and research has shown that the 
result of illness and whether people are incapacitated by illness depend on the 
symptoms as well as social and psychological factors (43). In reaction to the BM 
perspective, the BPS was proposed by Engel in a well-known paper entitled “The need 
for a new medical model: a challenge for biomedicine”(42), which contended that 
medicine as a discipline was in crisis and that this crisis was derived from adherence to 
a model that was not adequate for the scientific or social responsibilities of medicine 
and psychiatry. 
What individuals and society consider as health and the difference between being well 
and being ill will always be influenced by cultural, social and psychological 
considerations. A medical model that is based on a reductionist understanding, in 
which only biological factors are seen as determinants of disease, is not sufficient to 
meet the health needs of patients. A physician’s or health professional’s skills must 
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include social, psychological and biological aspects to be able to evaluate and 
recommend a course of action (42). 
That medicine is constantly being fragmented into new specialties has made the BPS 
more important and relevant (44). For example, dermatological conditions are 
associated with emotional suffering, reduced QoL, poor treatment adherence and 
disability, and these associations have led to the claim that psychosocial issues and a 
biopsychosocial approach to management of skin disease is warranted (23). As a 
subgroup of dermatological conditions, and although diverse in aetiology, 
photodermatosis can have a high psychological impact (26), negatively influence 
lifestyle (27), inflict high levels of anxiety and depression (24), and cause 
psychological distress that is related to the patients’ perceptions of illness (25). In the 
case of non-specific pain, it has been argued that improved patient outcomes in terms 
of distress require consideration of the disease characteristics as well as the 
psychosocial factors and that there should be a special focus on the patient’s 
perception of illness and its effects (43). 
2.2 The Common-Sense Model of illness perception 
The model of self-regulation of health and illness developed by Leventhal and 
colleagues (45, 46), which is referred to as the CSM in this thesis, is known by many 
names, and is also referred to as the Illness Perception Model, the Self-Regulatory 
Model or the Parallel Process Model (47). Self-regulation refers broadly to humans as 
active agents and decision makers; compared with other living creatures, humans have 
the ability to exert control over their impulses and to adapt and change behaviour to 
attain certain goals (48). Important features of the self-regulation models include the 
parallel processing of both problem-focused and emotion-focused goals to successfully 
control the objective problem and to regulate the emotional distress. Another key 
theme is the distinction between abstract processes, such as factual and conceptual 
knowledge and concrete–experiential processes, which include perception, experiences 
and memories. What separates the CSM from other more general self-regulating 
theories (such as Lazarus and Folkman’s stress-coping theory) is that the CSM applies 
specifically to health and illness (46). In the CSM, the emotional and cognitive 
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representations of illness are processed in parallel through three stages in a feedback 
system. The first stage is the definition or representation of the problem, the second is 
the planning and execution of a coping plan, and the third is appraisal of the coping 
response to determine whether it has brought the individual closer to the goal of 
coping (45). 
Early research based on common sense and subsequent investigations identified five 
dimensions of cognitive illness representations: identity, consequences, causes, 
timeline and controllability. Identity refers to the ideas, label, nature and symptoms a 
person views as part of the disease. The consequences component refers to the 
seriousness of the illness and its likelihood of affecting the person physically and 
psychosocially. Causes refer to internal or external causes. The timeline indicates the 
respondent’s perception of the likely duration of the health problems. Controllability 
refers to whether the disease is perceived as preventable, curable, or controllable (46). 
The key themes within the CSM are that people use common sense based on both 
knowledge and experience when they form representations of their illness and they test 
out these representations through both problem-focused and emotion-based coping. 
According to the CSM, the individual’s beliefs about his or her condition will be 
influenced by factual knowledge, personal experience, social context, discourses with 
health professionals, the media and other people’s opinions, and these beliefs may or 
may not be biomedically accurate (47). 
2.3 Horowitz’s stress-response theory 
In the present study, distress is defined as two main responses to stressful life events: 
intrusion and avoidance. Intrusive feelings are characterized by unbidden thoughts and 
pangs or waves of strong feelings, such as troubled dreams or repetitive behaviour. 
Avoidance responses include “denial of the meanings and consequences of an event, 
blunted sensation, behavioral inhibition or counter phobic activity and awareness of 
emotional numbness” (41). The development of the two response subtypes was based 
on both field observations and clinical studies (41, 49, 50). Horowitz’s stress-response 
theory provides an understanding of the processes involved in people’s reaction to 
stressful events. According to this theory, a stress response comprises alternating 
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phases of intrusion and avoidance (41). The general pattern can be described as: 1) 
initial realization that a stressful event has occurred; 2) a phase of emotional numbness 
and denial; 3) a mixed phase of alternating between intrusive feelings and compulsive 
or repetitive behaviour; and 4) a working-through phase during which acceptance is 
initiated and there is a loss of domination by the stressful event. 
The phasic relationships between intrusion and avoidance (initially described as 
intrusive-repetitive and denial-numbness symptoms) (51) are general responses, and 
every person does not necessarily enter every phase or enter the phases in a fixed 
sequence. A person can experience both avoidant and intrusive feelings 
simultaneously as a response to the same stressful event, but each may be oriented 
towards different aspects and meanings of the event in question. Horowitz uses the 
death of a spouse as an example—the bereaved may experience avoidant feelings 
towards the loss of a beloved one but at the same time feel intrusive thoughts that 
appear as emotional and angered behaviour towards the departed (51). 
A key finding of both clinical field studies and experimental studies is that, after a 
traumatic experience, there is a compulsory tendency for symbolic repetition of some 
aspects of the event and that psychic trauma is more important than physical trauma in 
precipitating the stress response (51). Avoidant behaviour is often related to defensive 
and unconscious processes needed to restore emotional equilibrium and to reduce 
conceptual chaos. Because these processes are unconscious and not felt directly by the 
individual, the term “avoidance” instead of “denial” was used in later work (52). These 
two responses to stress are considered general and can occur in varying intensity and 
after stressful events of different magnitudes, and apply to both acute and chronic 
stress reactions (51). 
PURPOSE OF THE STUDY 
To facilitate and optimize follow-up and patient care, including GC and general 
counselling of this patient group, further information about the health-related 
challenges faced by persons with AIP and PCT is needed. 
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3.1 Overall objective 
The main objective of this study was to investigate the psychosocial and health-related 
challenges that persons with AIP and PCT face. 
3.2 Specific aims 
The specific aims of the present PhD project were: 
• To investigate the subjective experiences of adolescents and young adults who 
were genetically tested for AIP as minors and to identify the psychosocial 
consequences and how they are handled. 
• To explore the experiences of persons with PCT concerning symptoms, 
treatment, prevention and follow-up. 
• To describe and compare illness perception, self-reported health complaints and 
psychological distress in persons with various activity of PCT. 
• To examine the associations between illness perception, self-reported health 
complaints, PCT symptoms and psychological distress. 
 MATERIAL AND METHODS 
The present project focused on an area of expertise that has attracted only a modest 
amount of research. On this basis, it was considered appropriate to use an inductive 
and exploratory approach with qualitative methods. Research based on qualitative 
methods can provide independent and valuable results and can act as a hypothesis-
generating approach for further studies. We wanted to perform a follow-up study that 
might be generalized to the population (paper III). Although all three papers can be 
viewed as individual and independent studies, papers II and III were designed to 
complement each other, and the overall design of the thesis can be defined as a multi-
methods approach (53). We believed that using different methodological approaches to 
a research area with little prior formal knowledge would provide a solid basis for 
exploring the present study’s objective and for contributing new insights and valuable 
results. 
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Table 2. Overview of study designs 
 Method Participants Design 
PAPER I Qualitative study Ten young mutation carriers for AIP 
tested predictively as minors 
Individual interviews 
PAPER II Qualitative study 21 adults with PCT symptoms during the 
past 5 years 
Focus group interviews 
PAPER III Quantitative study 263 persons with PCT Cross-sectional postal survey
4.1 Studies I and II 
Both studies I and II were qualitative studies that used interpretive description (ID) as 
a methodological approach. In study II, the analysis was inspired by systematic text 
condensation (STC) to aid reflexivity and transparency of the analytical process. 
4.1.1 Interpretive description 
ID is a research strategy developed by Canadian professor in nursing, Sally Thorne, 
and colleagues (54-56). The primary point of view is that health and nursing sciences 
are applied and practical disciplines that are not theoretical or academic by nature. The 
objective of ID is to offer health personnel a qualitative approach oriented towards 
pragmatic and practice-related research without committing to a certain theoretical 
position. Through an eclectic approach, knowledge that is relevant and applicable to a 
complex clinical setting can be created. This approach builds heavily on well-known 
traditions such as phenomenology, grounded theory and ethnography, while also 
adding something new and substantial by providing both a name and rationale for its 
development, instead of “watering down” or modifying and violating better-known 
methodological approaches developed in more academic disciplines (56). ID is a 
sensible qualitative approach in projects that use both qualitative and quantitative 
methods because it is based on pragmatic ideas and values both objective and 
subjective knowledge as important in the health sciences (56). 
ID is an eclectic approach that allows one to break from specific genres, but some 
elements are emphasized. The objective in an ID study should stem from two sources: 
an actual practice goal and an understanding of what is known and unknown about the 
research area based on all sources of available empirical evidence (56, p 53). Data 
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collection and analysis should be performed simultaneously (i.e., the constant 
comparative method), so that they can influence each other mutually. One should 
avoid early and too-rigorous and detailed coding. The ideal aim of the analytic process 
is to present understanding and conceptual phenomena rather than mere descriptions, 
and the purpose and recipients of the research will be influential in terms of which 
results are emphasized and presented. By respecting the essence of various qualitative 
traditions but at the same time viewing method as a dynamic interplay with the 
researcher, method can accommodate the research, rather than vice versa. A coherent 
and accountable relationship between analytic technique, methodological approach, 
and the knowledge abstracted must be present in such a way that the end product 
provides relevant and meaningful results that contribute to expanding the knowledge 
front in the research area, and has potential implications for practice. 
The fact that the health sciences are practical and not academic disciplines by nature 
influences how it relates to theory and philosophy, and provides challenges to the 
validity and credibility in qualitative research (56, 57). It is argued that one cannot 
know “the truth” because this will always be complex, contextual, constructed, and 
ultimately subjective (54). As one gives up the search for the absolute truth, one can 
still value knowledge as “probable truth” or as the best available at this moment. All 
qualitative research is deeply rooted in the contextual, although many qualitative 
researchers do not recognize that the disciplinary or historical context also influences 
their own perspectives. Acknowledging that “contextual awareness” that “we cannot 
see what we cannot see”, and that our “truths” are social constructions, is essential. 
The objective of ID is to present knowledge that can have practice implications. In the 
applied sciences, all knowledge can influence clinical practice and cannot be regarded 
as purely theoretical. This requires careful consideration and a pragmatic obligation. 
One must therefore defend why the knowledge generated is necessary and why it is 
important by considering that the knowledge revealed can be misused, for instance 
with regard to marginalized groups. This is what Thorne refers to as moral 
defensibility. The research and knowledge produced should be both necessary and 
relevant to the discipline in question (56). 
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4.1.2 Participants 
Qualitative research involves a number of sampling procedures such as the theoretical, 
purposive and convenience samples, among others. 
In study I, we chose a theoretical sample of persons we deemed most eligible to 
provide information about and insights into the question at hand. Theoretical sampling 
is based on the idea of maximum variation and is a strategy developed from grounded 
theory, in which one deliberately seeks out specific cases based on initial hunches or 
developing patterns. In ID, where the aim is to uncover clinically relevant knowledge 
and not formal theorizing as in grounded theory, one does not require the same open 
theoretical sampling, although the principle of reserving some of the sampling criteria 
until one is underway in the data collection still applies (56, p 92). We wanted to 
explore the experiences of persons who had been genetically tested before they were 
16 years old, but at the same time we wanted them to be old enough to have reflected 
on the testing and possibility of having the disease. Considering this rationale, we 
chose to include persons between the age of 16 and 21 years. This meant that only a 
limited number of participants met the inclusion criteria. Of the 28 persons eligible, 12 
gave their consent but only 10 were able to participate in the interview. 
In study II, we chose a convenience sample in connection with a biennial patient 
seminar arranged by NAPOS. The rationale was that we could recruit participants 
from the entire country and that that we expected that attendees at the seminar who 
were interested in participating in our study would provide important information 
about their experiences with PCT. Convenience sampling is a sample based on “pure 
convenience” and can be a good source of insight for the applied qualitative 
researcher, especially when there is little prior knowledge of the phenomenon at hand. 
However, it is also an approach that requires careful reflection on and attention to how 
the specific context can make the sample different from the general population of these 
patients (56, p 89-90). 
Considering that we believed that participants at the seminar might provide the 
information needed to answer the research question, one could argue that this sampling 
had an element of purposive sampling. In purposive sampling, one tries to identify in 
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advance the important conditions or groupings that may contribute to the findings’ 
relevance for the intended audience. Based on ethnography, an important concept of 
purposive sampling is the “key informant”. Although this might be difficult to identify 
in a clinical setting, the ideal informants in an ID might be people who are articulate 
and who can reflect on the experiences one wishes to explore (56, p 90-91). 
The invitations to participate in the focus groups were mailed along with the 
invitations to the patient seminar. This meant that persons not attending the seminar 
had the opportunity to participate in the focus groups, and we planned to organize 
additional focus groups if we did not obtain enough information during the patient 
seminar. However, no one who did not attend the seminar provided consent to 
participate in the focus groups. Considering the rich material provided by the three 
focus groups, we did not consider it necessary to arrange additional focus groups. 
4.1.3 Individual interviews 
In study I, the data were collected in individual qualitative interviews of 10 young 
persons who had been predictively tested for AIP as minors (<16 years of age). 
Qualitative interviews are generally referred to as structured, with a structured 
questionnaire, semi-structured, with an interview guide and open-ended questions, or 
in-depth, in which a few issues are covered in great detail and the questions are based 
on what the interviewee says. We used a semi-structured approach and an interview 
guide with main topics and open-ended sub-questions, but with the opportunity to 
diverge by pursuing responses or new topics of interest.  
The qualitative research interview is a special meeting between people. It is important 
to recognize that clinical and qualitative research interviewing is quite different in both 
nature and purpose (58). For clinicians in the health field, interviewing is a familiar 
activity; however, the skills learned through clinical interviewing are not necessarily 
appropriate for qualitative research interviews (56, p 78). From the clinician’s point of 
view, the purpose of an interview is to find answers to questions so that proper 
management of the patient’s condition can be established. As such, open-ended 
questions are less useful because the clinician must seek conclusions, usually within a 
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limited amount of time. By contrast, in the qualitative research context, the aim is to 
discover the participant’s own meanings and to avoid making or imposing assumptions 
(58). This means that new ideas or themes that were not anticipated can strengthen the 
study and provide the kind of data that are unique to qualitative research. 
Because human communication is so intertwined with the context and social setting, 
and is a dynamic process that affects both the interviewer and the interviewee, it is 
important to be aware of how the double role of being both a (genetic) counsellor and 
a researcher might affect the participants. When performing qualitative research, it is 
important to consider how one is viewed by the participants, and this is especially 
important when the researcher is a health-care worker. Although there is no 
therapeutic intention, there is a potential for insight and reflection by the participants. 
By asking “tell me more about that” or “can you elucidate or clarify”, interviewees can 
be challenged to contemplate their experiences and, consequently, to discover new 
connections and meanings and to develop new insights into their experiences. In this 
sense, just by interviewing participants about their experiences, the experience itself 
changes and takes on new aspects to consider. Research interviews are an active 
process, and non-directiveness and being aware of potential leading questions are 
essential (58). To be able to produce relevant and clinically important results with 
potential applications, it is vital that the data collection is performed with reflexivity 
and humility so that the interviews do not simply reflect the researcher’s own 
personality, passion or expected findings (56, p 129). 
All interviews were performed by the first author. Five interviews were performed at 
each participant’s home and five were performed at a hospital close to each 
participant’s home, as chosen by each participant. The participants came from 
different parts of Norway, and all but one interview required the interviewer to travel 
some distance. All interviews were performed on separate dates, except for two that 
were performed on the same day because they were in the same city, to which the 
researcher was required to travel. 
Each interview started with an introduction to the interviewer and a presentation of 
what to expect from the following session. It was noted that there were no right or 
35 
wrong answers and that it was the participant’s own experience that was of interest. 
The right of the participant to withdraw consent to participation at any time before 
publication was mentioned explicitly. The participants were told that the interviewer 
would strive to achieve full anonymity but, with qualitative findings and presentation 
of quotes, this could not be guaranteed. Permission was asked for the interviewer to 
contact the participants by telephone for clarification in cases of uncertainty about the 
meanings or statements, although this was not considered necessary. All interviews 
were audiotaped and field notes were taken. In one of the interviews, the tape recorder 
malfunctioned, and an additional 20-minute session was required during which the 
participant was asked to repeat some of the most striking and interesting information. 
4.1.4 Focus groups 
Focus group studies are designed to provide distinctive types of data based on the 
interactions between and discussion among the participants, and in this way to 
capitalize on the different experiences of the participants (58). Although originally 
developed for use in communication studies of mass media, marketing and advertising, 
it has become popular in a number of fields, including health sciences (59). We found 
focus groups appropriate for studying PCT because of the long, perhaps lifelong, 
periods of remission and we expected that some of the participants would have few 
experiences with PCT. Hence, we anticipated that communication between 
participants could help to elucidate the different aspects of their experiences with PCT. 
When determining the number of focus groups needed, it is often considered a rule of 
thumb that three to five groups can provide “saturation”; that is, that one can anticipate 
that adding more groups will not generate new understandings or insights (60). There 
are several factors to consider when determining the number of participants in a group. 
Larger groups will typically require greater participation by the moderator, which is 
generally undesirable and demands skills of the moderator, but can be advantageous if 
the topic is something that the participants have little involvement with. An 
appropriate number of participants is generally regarded to be between six and 10 
participants, depending on the topic and research question. Sustaining the discussion 
might be difficult with fewer than six but difficult to manage with more than 10 (59, 
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60). We recruited 21 participants and found that three groups of seven participants 
each was optimal. In our experience, the size of the groups was appropriate because it 
allowed a good pace and discussion among the participants, who seemed to participate 
enthusiastically; although some were more verbal than others, all participants could 
voice their opinions. 
Some homogeneity of the group composition is generally advantageous for enhancing 
interaction and making the participants feel comfortable enough to discuss the topic at 
hand (60). When planning the composition of the groups, we tried to achieve a 
somewhat equal combination of women and men, and we set as inclusion criteria that 
all participants would have some experience with PCT symptoms during the past 5 
years. Because of last-minute changes by some participants, the two first groups had a 
similar number of men and women whereas the third group had five women and two 
men. The groups had similar discussions, although there were some differences in 
group dynamics, which meant that some topics received more attention in some groups 
than in others. 
The first group can be informally called the “chronic group”. This group had a 
comprehensive discussion of the topic of the health complaints that can be attributed to 
PCT. Some of the participants had chronic health complaints, such as tiredness and 
fatigue, brought this aspect into the discussion more than the two other groups. The 
second group can be referred to as the “blood-values group”. They were more 
interested in ferritin level and when to start phlebotomy than were the other groups. 
The third group can be labelled “the horror stories group” because they discussed the 
most dramatic depictions of PCT. However, it must be emphasized that the groups did 
not differ to the extent that labelling them as different groups is justifiable; that is, the 
informal labelling presented here is included only to show that the group dynamics can 
differ and how one person in one group can shift the focus and direction of the 
discussion and the interplay between the participants. 
Moderator involvement refers to the degree to which the moderator manages the group 
dynamics by controlling the discussion (60). In our focus groups, we used a semi-
structured interview guide (see Appendix 1). Free discussions among the participants 
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were encouraged. Moderator involvement was limited to specific situations such as 
moving to a new topic at the end of each discussion, when discussion strayed from the 
research question, or when some participants were not contributing to the extent that 
they wished. If interesting points came up and a more thorough elucidation of that 
topic was wanted, the moderator used the field notes and waited for an appropriate 
moment to follow up on the statement. However, because of the limited time and 
number of participants, the moderator sometimes need to take a more active role in a 
focus group interview than in an individual interview. Two co-moderators (one in each 
group) aided in the management of the three focus groups. Both had experience in 
qualitative research and were knowledgeable about porphyria. Their main tasks were 
to help in any unexpected situations, for instance if somebody knocked on the door 
during the focus group interview and asked a question. Otherwise, they were asked to 
take notes on the participants’ statements, which was helpful in identifying the speaker 
in the later transcriptions. In hindsight, this may not have been necessary because the 
participants came from different parts of Norway and had distinct dialects and, 
although the discussions became lively, the participants were good at waiting “their 
turn” for speaking. 
4.1.5 Analysis  
In qualitative literature, the words “theme” and “categories” are sometimes used 
interchangeably. The following definitions are used in this presentation of the 
analytical steps used in papers I and II. A category or code group is a “collection of 
similar data sorted into the same place, and this arrangement enables the researcher to 
identify and describe the characteristics of the category”. A theme is “a meaningful 
‘essence’ that runs through the data” (61). This implies that, when describing the 
analytic process, the categories are used as a working step towards developing the final 
themes presented in the articles. 
ID allows the researcher to use the analytic approaches that are appropriate for 
answering the research question at hand. Instead of committing to a certain 
philosophical or theoretical position, a pragmatic and eclectic approach, which is 
based firmly on reflective decisions, is considered to be more appropriate and better 
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suited to aid the researcher’s creative processes to achieve relevant and fruitful results. 
This implies that ID does not provide any rigid step-by-step “recipe” for producing 
sound research results but instead refers to recognized and well-established procedures 
that the inexperienced (or experienced) researcher might use. No such step-by-step 
instructions should be followed blindly or uncritically because this could result in 
technique overshadowing creativity in the process and introduce the risk of ending up 
with empty and meaningless results (56, p 153). 
When it comes to analytic approaches, ID allows for a variation of techniques and 
traditions, as long as the use is based on a logical, systematic and transparent process 
relevant to the research question at hand. This means that deviance from the standard 
procedure is not necessarily wrong, but rather what Sandelowski (Sandelowsky in 
foreword 56) calls strategic non-compliance. It is the researcher and not strict devotion 
to the analytical rules that should drive the interpretation. Creativity and intuition are 
therefore important, and a too-rigorous coding process can cause the loss of important 
insights. It is therefore recommended that, as a point of exit, the analysis takes a wide 
focus and is sceptical of the immediate impressions by taking care not to start a too 
detailed coding process too early. This will help to prevent premature coding 
threatening the process by blinding the researcher (56, p 145-147). All ideas and 
frameworks that are brought into the study must be carefully examined and noted so 
that they do not influence the researcher in ways that may not be intended. This might 
be harder to do in studies related to disciplinary knowledge compared with those based 
on formal and explicit theories (56, p 99).
The analysis presented in paper I is described in a short and general way, and a more 
thorough description is presented here. This analysis was based mainly on an ID 
approach; however, given that the first author had prior experience with STC, this 
influence should be considered. After eight of the 10 interviews were completed and 
transcribed verbatim, the total text was read as a whole, and as the last two interviews 
were completed, they were incorporated into this holistic reading. The text was then 
transferred into QSR N6 Software (QSR NUD*IST. Qualitative Research and & 
Solutions Pty Ltd., 1997). The reading identified nine categories: 1) disease in the 
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family; 2) own disease; 3) predictive testing; 4) information; 5) seriousness; 6) 
psychosocial aspects; 7) positive aspects; 8) negative aspects; and 9) GC. These 
categories were identified in the text based on the research question but also mirrored 
the interview guide to some extent. The categories were deliberately created as open to 
avoid the premature closing of categories. 
Using these categories, each informant’s interview was then coded. Text that did not 
provide meaning related to the research question was removed. At this step, quotes 
that seemed to stand out were collected in a separate document. In the next step, 
summaries of each category were decontextualized so that they were no longer based 
on individual interviews, which allowed for cross-case combinations. Using these 
summaries, an iterative process was started in an attempt to present the meanings 
identified in the previous categories. This process was lengthy and, after several 
rounds of going back to the text as a whole and looking at the decontextualized text, 
four themes emerged. At this stage some choices were made about which results 
would be prioritized and presented under each theme, and whether the results would be 
relevant to the intended audience. As a final analytic step, the total text was read as a 
whole, and all of the interviews were listened to again, with the completed themes in 
mind, to ensure that meaning was not lost or added in the analytic process. 
4.1.6 Analysis paper II: Systematic text condensation 
The analysis in paper II was influenced and inspired by STC (62) but not followed 
strictly. STC was initially developed as a strategy for guiding novices in qualitative 
analysis. It is easy to share and aids transparency in the analytic process (62), which 
was one of the main motivations for using this approach in paper II. STC is a strategy 
for qualitative analysis elaborated from Giorgi’s psychological phenomenological 
analysis four-step procedure. STC is an explorative approach whose aim is not to 
cover the full range of experiences but rather to present possible and vital experiences 
of a phenomenon on a descriptive and conceptual level. A decision trail was used to 
aid both reflexivity and transparency in this process. However, as Malterud says, the 
analytic process can never be fully articulated (62). 
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STC follows four steps. 
Step 1: Obtaining a total impression and overview of the data. 
At this point, one tries to stay atheoretical and to avoid preconceptions. In the analysis 
of paper II, this was done by reading the transcripts from all of the interviews as a 
whole while keeping an open mind and avoiding systematizing the results. In STC, as 
in ID, stepwise analysis is recommended, and the reading of transcripts should start 
before all the data are gathered. In STC, one of the reasons for this is to keep the 
amount of data manageable. Because all three focus groups were held on two 
consecutive days, this was not feasible and the total data material was read as a whole, 
although there was some informal analysis immediately after each focus group. At this 
stage, four preliminary themes were identified as a basis for further analysis: 1) large 
variations in symptom experience; 2) taking control; 3) treatment; 4) prevention of 
symptoms. 
Step 2: Identifying and sorting meaning units. 
At this stage, the data are organized systematically by going through the text and 
coding the meaning units. A meaning unit is a text bit containing some meaning 
relating to the research question. The meaning units are sorted into categories. Both 
STC and ID recommend a very flexible process and that rigid coding should be 
avoided (56, 62). In paper II, this was done by first sorting the identified meaning units 
under the four preliminary themes identified in step 1, which now functioned as 
categories. This process involves decontextualizing data by removing them from their 
original context. This was performed across cases, following the natural sequence of 
the focus group communication by manually cutting sections out of the transcripts 
using the word processing copy–paste function and inserting them into new 
documents. 
Step 3: Condensing from code to meaning 
In STC, the empirical data have now been reduced to, in our case, four code groups. 
Each code group was then analysed internally by sorting meaning units into 
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subgroups. In STC, an artificial quotation is produced based on the condensed 
subgroup; however, this was not done in our analysis. Instead, we synthesized the 
meaning units that were collected across cases into “coherent” statements belonging to 
each individual participant in the focus groups. In paper II, this is called “longitudinal 
coding at an individual level” for every subcategory. This was done to see more 
clearly each individual’s “narratives” and provided a step towards understanding the 
material in depth. This was done both for the entire empirical material and on the 
subcategory level, in addition to the initial cross-case analysis. 
Step 4: Synthesizing from condensation to descriptions and concepts 
This final step in the analytic process is to re-conceptualize and present the 
descriptions and concepts that can form credible stories to elucidate the research 
question. In this process, the researcher takes on the role of re-narrator. In this 
research, this was (as always) a lengthy and iterative process, which involved making 
sure that meanings were presented conscientiously while recognizing that this is a 
“multivocal synthesis” that is not expected to represent every participant’s exact 
meanings (62). This step results in a condensed and more abstract presentation of the 
meanings in each main theme. Identifying headings for the themes and sub-themes is 
considered an important part of the analysis and is expected to express a highlighted 
perception of what the study adds. As a final step, the total text was re-read several 
times while systematically searching for data that challenged the results. 
4.2 Study III 
Paper III is based on a cross-sectional questionnaire mailed to all persons older than 18 
years and registered with AIP or PCT at NAPOS. In this paper, only data from the 
PCT population was used. 
4.2.1 Study population 
Of the persons registered with PCT at NAPOS, 40 were excluded. Thirty-four of these 
were because they had sPCT but there was no contact or analysis of samples 
performed during the preceding 10 years. Three were registered with an unknown 
address and three had an unclear diagnosis or subclinical PCT. Of 484 included 
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persons, 272 returned the questionnaire (56%). One hundred and seventy responses 
were returned after the primary dispatch (May), and 80 and 22 were returned after the 
first (June) and second reminder (October), respectively 
Twenty-five persons did not participate for the following reasons. Two were deceased, 
nine were returned marked with “address unknown”, nine returned their consent form 
stating they did not want to participate, two returned the questionnaire unanswered, 
one could not participate because of health issues, and two contacted NAPOS with 
questions regarding their diagnosis, and were consequently excluded because of 
subclinical PCT. The total of 186 non-responders included 82 women and 104 men. Of 
these, 15 were registered as having latent PCT and 171 as having active PCT. Their 
age ranged between 20 and 95 years: 43 were younger than 50 years and 143 were 
older than 50 years. After exclusion of nine participants who had returned the 
questionnaire but had not answered the question about disease activity, a total of 263 
participants were included in the final analyses. This resulted in a total response rate of 
54%, although the number of respondents varies in the statistical analyses because of 
missing items on some scales. 
4.2.2 Patient-reported outcomes 
A PRO can be defined as “a measurement of any aspect of a patient’s health status 
that comes directly from the patient, without interpretation of the patient’s responses 
by a physician or anyone else” (63, p 8). In paper III, self-reported health complaints, 
illness perception and porphyria-specific distress were analysed in addition to various 
data about demographics and self-reported disease activity. A presentation of the three 
standardized and validated measurement instruments used in paper III follows. The 
instruments and demographic questions are presented in Appendix 2.  
4.2.4 The Brief Illness Perception Questionnaire 
The BIPQ is defined as a “nine-item scale designed to rapidly assess the cognitive and 
emotional representations of illness” (40). The original Illness Perception 
Questionnaire (IPQ) assesses the five cognitive illness representations adapted from 
the CSM of Leventhal et al (64). A revised version of the questionnaire (IPQ-R) 
elaborated the model further by splitting the control component to personal and 
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treatment control and adding the assessment of emotional representations of illness, 
which is an important aspect of the CSM. Finally, a new dimension to assess the extent 
to which the illness representations provide a coherent understanding of the illness was 
incorporated (65). 
In this study, we used the BIPQ Norwegian version (66), which is a shorter version of 
the 80-item IPQ-R. Because we used a battery of instruments in the full questionnaire, 
the shorter BIPQ was deemed more suitable. The BIPQ has satisfactory validity and 
reliability and provides a rapid assessment of illness perception, which could be 
particularly useful in large-scale studies (40). Five items measure cognitive illness 
representations (consequences, timeline, personal control, treatment control and 
identity), two items assess emotional representations (concern and emotions), and one 
item assesses illness comprehensibility (coherence). In the present study the 
instrument was made porphyria specific; for example, the word “illness” on the 
general BIPQ version was changed to “porphyria” (see Appendix 2). 
Responses to the first eight items are measured on a continuous 10-point scale. The 
ninth item comprises an open question about the causal explanation of the disease. 
This last item was not used in our study (paper III). According to the literature, a total 
score can be computed, and higher scores indicate a higher perceived threat by the 
condition (40). In the present study, the internal consistency (i.e., the degree of 
interrelatedness among the items (67)) of the total scale was checked by calculating 
Cronbach’s alpha and was found to be adequate (Cronbach’s alpha = 0.67)(63, 68, 69). 
4.2.3 The Subjective Health Complaints Inventory 
In the present study, self-reported subjective health complaints (SHCs) were measured 
using the Subjective Health Complaints Inventory. An SHC has been defined as a 
measure of “…the occurrence and severity of somatic and psychological complaints. It 
records ailments based on objective diseases, but is particularly sensitive to health 
complaints with minimal or no clinical findings” (70). Others have defined SHCs as 
“all health complaints experienced by a person” (71). 
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The aim of the SHC is not to arrive at new diagnoses or disease classifications, but 
may be a useful tool to follow the well-being, or lack of such, in individuals or specific 
groups of individuals. The SHC “seem to be a fast, inexpensive, simple and reliable 
way to assess SHCs as they occur in the normal working population, without 
diagnoses, hypotheses or attributions” (72). The Subjective Health Complaints 
Inventory measures both the frequency and severity of self-reported health complaints 
during the past 30 days on a 0–3 Likert scale without mapping the diagnosis or 
symptom attributions. The instrument is a 29-item scoring system that is categorized 
into five subscales: musculoskeletal complaints (headache, neck pain, upper back pain, 
lower back pain, arm pain, shoulder pain, migraine and leg pain); pseudoneurology 
(palpitation, heat flushes, sleep problems, tiredness, dizziness, anxiety and 
sadness/depression); gastrointestinal (gas discomfort, stomach discomfort, diarrhoea, 
constipation, gastritis/ulcer, heartburn and stomach pain); allergy (allergies, breathing 
difficulties, eczema and asthma); and influenza (cold/flu and coughing) (72, 73). The 
instrument has shown satisfactory reliability and validity (72). In the present study 
(paper III), only the mean total severity scores was assessed.  
4.2.5 The Impact of Events Scale 
The IES is defined as “a broadly applicable measure of subjective distress relating to 
any life event” (41). In the original instrument, IES was found to have satisfactory 
reliability as shown by adequate test–retest results. Sensitivity was tested by 
calculating the expected and relevant differences in self-reported responses to life 
events of varying magnitude and by detecting changes observed by experienced 
observers (41). A review of the psychometric properties of the scale concluded that the 
instrument is a useful measure of stress reactions after a range of life events, and that 
the two-factor structure has satisfactory reliability and validity and can be used 
clinically to discriminate between mild and severe distress (52). A later review 
concluded that “the IES performs very well as a self-report instrument for subjective 
psychological distress related to a specific stressor”(50). In paper III, we chose to use 
the term “psychological distress” when referring to the measured responses of 
intrusion and avoidance, and this term is used throughout the present thesis. 
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Although the IES was not developed to assess post-traumatic stress disorder (PTSD), 
the instrument is used widely as a measure of PTSD. This has led to criticism of its 
content validity because it does not contain items covering hyperarousal, a diagnostic 
criterion for PTSD. As a result, a revised version of the IES has been proposed (IES-
R) (49), which aims specifically to assess and diagnose PTSD. 
In paper III, the instrument was made porphyria specific by adding the word 
“porphyria” to all 15 questions; for example, item 1 was changed from “I had waves of 
strong feelings about it” to “I had waves of strong feelings about porphyria” (see 
appendix 2). In the original development of the instrument, the anchoring to a specific 
context was done by entering the life event at the top of the form (41). 
4.2.6 Statistical analyses 
One-way Welch analysis of variance (ANOVA) was performed to determine whether 
scores on the BIPQ, SHC total score, and IES intrusion and avoidance differed 
between the three PCT subgroups (Table 2, paper III). There were some outliers, as 
assessed by boxplots, and the data were not normally distributed for each group, as 
assessed by the Shapiro–Wilks test. There was heterogeneity of variances, except for 
three BIPQ items (treatment control, coherence and overall BIPQ), as assessed by 
Levene’s test of the homogeneity of variances. A one-way Welch ANOVA was 
consequently used to identify differences in scores between the three PCT subgroups 
because this is considered an appropriate test when there is heterogeneity of variances 
(69). 
In the multiple linear regression analysis, those scoring 0 on the IES subscales were 
removed from the analysis, and the remaining participants were included. The analysis 
of the subscale intrusion included a total of 51 participants who reported active 
symptoms and a score >0 and 155 who reported remission or latent disease and a score 
>0. For the avoidance subscale, the corresponding numbers were 50 and 139, 
respectively. Because of non-normality, the variables were log transformed in the 
multiple linear regression analysis (Table III, paper III) and the logistic regression 
analysis. The variables were back transformed to their original units in the results 
presented (Table III, paper III). We also performed control tests to determine whether 
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other psychosocial factors such as cohabitation or employment status (working/not 
working) were significant predictors of porphyria-related distress. However, entering 
these factors into the multiple linear regression models did not change which 
independent variables (IVs) came out as significant. 
Scoring of the PROs and the handling of missing data were done according to the 
scoring manual for the BIPQ (40, 74), IES (41) and SHC (72).  
ETHICAL CONSIDERATIONS 
The three empirical papers and the present thesis comply with the Declaration of 
Helsinki. All the three studies were approved by the Norwegian Regional Ethics 
Committee; the reference numbers are: paper III: 2010/149; paper II: 2012/1078 and 
paper I: 2008/9943-ØYSV. In paper I, the guidelines at the time of the study also 
required permissions from the Norwegian Social Science Data Service, and the 
necessary approval was gained (reference number 19838/2/GRH). 
For all participants in both the qualitative and quantitative studies, informed written 
consent was required for participation. 
For participants younger than 18 years of age (paper I), written consent was obtained 
both from the participants and their legal guardian.   
The objective of interpretive descriptive research is to present knowledge that may 
have practice implications. This means that one must defend why the knowledge to be 
generated is necessary because of the potential risk that such knowledge can be 
misused, for example, in regards to marginalized groups. This is what Thorne refers to 
as the moral defensibility of the research performed (56). When performing predictive 
genetic testing of minors for a disease for which there are no guaranteed actions that 
will improve prognosis, it seems evident that an investigation of the effects such 
testing might have is easily defended. In the case of paper I, however, both the results 
and the research process itself needed to be assessed. Discussing life situations with 
young participants is very personal and may be a new situation for many participants. 
There might have been some problematic aspects that emerged that did not have 
anything to do with porphyria but gave rise to the realization that the situation could be 
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ethically challenging. Some participants opened up during the interview, but there was 
no opportunity to follow up on their personal stories. On the other hand, this may not 
necessarily only be negative. As mentioned earlier, the aim of a qualitative interview is 
not therapeutic, but having the opportunity to reflect on one’s own situation can be 
beneficial and thus may have a positive and therapeutic effect. However, one cannot 
ignore that the interview itself may have altered the young participants’ perception of 
the disease—for better or worse. 
Qualitative studies have some problematic issues such as the potential for 
identification of participants because their pseudonyms are attached to the quotes 
presented in the text and tables. This problem was contemplated, but we found it 
important to contextualize the quotes and to provide some background information, 
and consequently we judged this to be acceptable. The problem of anonymity was an 
extra challenge for the focus groups, as in any group situation, and this was addressed 
explicitly in each group. All the focus group members were requested not to share any 
of the information they had learned outside of the group, which in other situations may 
have been difficult because they were participating in a patient seminar and expected 
to share their experiences. 
In the cross-sectional questionnaire study, participants were asked to return their 
written consent to participate together with the finished questionnaire. In a few cases, 
the questionnaire was returned without the consent. After discussions with 
representatives of the Regional Ethics Committee, we decided to consider the fully 
answered questionnaires as consent to participate and consequently chose to include 
them in the study. 
The recruitment of participants for the study in paper III may have had ethical 
implications because some of the people who were sent the questionnaire may not 
have known or considered themselves to have PCT. This was also an argument for not 
including persons registered with sPCT at NAPOS who had not had biochemical tests 
for >10 years. This was the feedback from two persons who contacted NAPOS with 
questions regarding the diagnosis. One had been predictively tested many years ago 
and did not know that he or she was a mutation carrier. The second person asked if he 
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or she had the disease, and the person in question proved to be diagnosed subclinically 
while being tested for another type of porphyria. 
SYNOPSIS OF RESULTS 
6.1 Paper I: Psychosocial aspects of predictive genetic testing for acute 
intermittent porphyria in Norwegian minors 
AIP was experienced as a vague condition, and participants and their relatives 
attributed a variety of symptoms to the disease. Early genetic testing and diagnosis was 
considered important and its perceived advantage was that the patient could take 
precautions by modifying lifestyle, but finding motivation for such modification was 
difficult. AIP posed few psychosocial challenges to the participants but although AIP 
was a small part of the participants’ identity, the risk of manifest disease was a cause 
of concern for some. This can be ethically challenging and underlines the importance 
of appropriate counselling. The participants were content with their present level of 
knowledge, but they expected this to change if their situation in life changed. 
However, they felt they could obtain relevant information when needed. 
6.2 Paper II: A skin disease, a blood disease or something in between? An 
exploratory focus group study of patients’ experiences with porphyria 
cutanea tarda 
Participants’ symptoms varied from fragile skin to what they described as a desperate 
situation comprising huge blisters, skin falling off and feeling as if in a “horror 
movie”. For some, itching was a considerable problem. PCT was perceived as being a 
blood rather than a skin disease, and this made participants contemplate whether other 
health issues were caused by PCT and if there were more to this disease than the 
specialists knew. 
Although most participants had not experienced relapses, they regarded PCT as a 
chronic disease that required controls and prophylactic phlebotomy for the rest of their 
lives. There were reports of frequent controls, blood tests and prophylactic 
phlebotomy. Treatment with phlebotomy was not without problems, but it caused 
rapid improvement and made the situation less dramatic. 
49 
6.3 Paper III: Illness perception and psychological distress in persons with 
PCT 
PCT is a disease that is accompanied by photosensitivity, and little is known about the 
patient’s perspective of this condition. Two hundred and sixty-three participants 
answered a cross-sectional questionnaire. One trend in their responses was that persons 
reporting activity of PCT symptoms also reported a greater perceived illness threat, 
more health complaints and greater psychological distress compared with those in 
remission or the latent phase. However, there was no association between self-reported 
PCT activity and higher scores on psychological distress. Perceived illness threat and 
total health complaints were associated with greater psychological distress. PCT was 
perceived as a chronic condition with strong personal and treatment control. This has 
implications for the clinical follow-up of PCT patients in both the active and remission 
phases. 
DISCUSSION 
This chapter is divided into a discussion of the most important empirical findings, 
which is followed by a discussion of methodological considerations. 
7.1 Discussion of the results and empirical findings 
The discussion of the most important findings is based on the specific aims formulated 
in the papers and the overall objective of this thesis. This section is divided into 
discussions of relevance for AIP and PCT combined, which is followed by a 
discussion of the results for AIP and PCT separately. 
7.1.1 Papers I–III: AIP and PCT 
AIP and PCT present with completely different symptomology and challenges and, for 
many clinicians, the choice to combine the two conditions in the same thesis might not 
be obvious. However, this is logical for the genetic counsellor working exclusively 
with porphyrias because of the focus on the two most common forms for porphyria, 
which have received little attention in terms of the patients’ subjective experiences. 
Results from all three papers in this thesis indicate that separating symptoms of AIP 
and PCT from other health complaints can be difficult. This was reported by the young 
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participants in study I, but was also evident in the comments made by their relatives. 
This was also evidenced in the data in papers II and III but was more unexpected 
because the symptoms of PCT are skin related and were not expected to be confused 
with other health complaints, except perhaps those associated with other 
dermatological symptoms. That patients with a confirmed diagnosis attribute various 
health complaints to their diagnosed condition is perhaps not surprising, but is it 
problematic? 
In paper I, some of the young participants worried that they would not be able to work 
full time if they developed active disease, a finding that shows that how the condition 
is perceived has important implications for the patients. In paper II participants 
reported inappropriate and frequent follow-up, blood tests and prophylactic 
phlebotomy. The results of paper III, in which psychological distress related to 
porphyria was associated with illness perception and total burden of health complaints 
but not with symptom activity, indicates that attributing general health complaints to 
PCT can be distress causing. This means that there is potential for overtreatment, 
medicalization and psychological distress related to attributing any health complaints 
to their condition. The theories of Horowitz and Leventhal were both developed partly 
with the aim of improving patient compliance with preventive measures and treatment 
of disease. To the genetic counsellor dealing with the risk of disease as much as 
disease itself, the point of departure is also that of avoiding medicalization of persons 
at risk for developing symptomatic disease. Medicalization can be understood as the 
increasing number of human aspects of life that are understood in medical terms (75). 
A recent Norwegian study showed that genetic counsellors and geneticists who 
provide GC in fact view it as a defence against medicalization (76). In this sense, one 
could claim that, as surely as clinicians and counsellors must understand porphyria in 
light of the biopsychosocial understanding of disease, it is also necessary to have a 
clearer definition of what constitutes AIP and PCT symptoms. Genetic counselling is a 
communication process aiming at helping individuals and families understand medical 
facts and diagnosis, and the probable course and what management is available, 
including understanding options for dealing with risk of recurrence in a sensible way 
(39). This perspective favours using the biomedical approach to defining an AIP attack 
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and the symptoms of PCT because patients risk further medicalization and 
overtreatment in interpreting any health complaint as a sign of AIP or PCT. This is 
something that should be debated and discussed continuously. In the latest guidelines 
for the follow-up of PCT patients, NAPOS advises that too-frequent controls for 
patients in remission might contribute to the medicalization of this patient group and is 
warned against. 
At a time when the risk of various diseases is gaining increasing attention, the 
possibility of predictive genetic testing means that persons may have to relate to 
diseases they do not yet have—and are likely to never develop. The CSM is a 
theoretical framework developed by psychologists to describe how individuals 
perceive and construct risk in relation to illness. This model recognizes that individual 
risk perception is not necessarily based on rational and objective risk estimates but is 
instead influenced by personal and others’ experience with illness, for example that of 
family members (77). This is illustrated in paper II by stories of family members who 
found it problematic to have children if one was a carrier of a pathogenic UROD 
mutation. There were also considerable discussions in the focus groups about whether 
they would want at-risk relatives to have predictive genetic testing. This underlines the 
ethical aspects and emphasizes the need for appropriate counselling about genetic 
testing. So how can we use these results in GC and predictive testing for AIP or PCT? 
Risk communication can be defined as “the open two-way exchange of information 
and opinion about risk, leading to better understanding and better (clinical) 
decisions” (Ahl et al 1993, pp 1047 in 77). Research has shown that individuals have a 
tendency to dichotomize risk—that is, they have either a higher risk or average risk. 
Simply offering people predictive genetic testing without proper counselling or the 
possibility of later updates and further counselling can be of little practical value and 
possibly damaging and distressing. Also in regards to Horowitz’ stress-response 
theory, a dose-by-dose strategy is suggested for people to deal with genetic test results 
(78). Although one would regard this intuitively as less important in low-penetrant 
conditions with good prognosis such as PCT, results from paper II and III indicates 
that the opposite may be true for some persons. A review article about the patient 
perception of clinical genetics found evidence that there is a tendency to overestimate 
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risk and that, although there is little evidence of the effect of this perception, a high 
risk estimation can affect health adversely and lead to inappropriate preventive 
measures (77). This is an argument of the need for health-care providers to understand 
patients from a biopsychosocial perspective while also maintaining a biomedical view 
of the disease itself. When possible, clear answers should be provided about what is 
caused by porphyria and, importantly, what is not. The BPM also acknowledges that a 
more biomedical approach is sensible for cases of exacerbation of chronic disease 
(42). 
7.1.2 Paper I: AIP 
In the case of predictive genetic testing of minors, information about risk was 
considered advantageous and beneficial, even when it did not include any explicit 
changes in plans for the future. That AIP was a small part of the participants’ lives and 
identity was a finding in itself. Participants did not change their lifestyles because of
AIP or in fear of developing active AIP. One should consider these findings in the 
context of the Norwegian health-care system. Norway is classified as a so-called 
“welfare state”; because of its strong petroleum-based economy, it is characterized by 
large public expenditure on public health-care services and extensive social securities 
(76). That three of the participants were clear about their expectations of active AIP as 
invariably resulting in impairment of their ability to work and that they might not be 
able to continue their chosen careers may have been discussed differently if these were 
young adults in countries where they could not expect to be cared for by the welfare 
system if unable to work. One would expect that the risk of not being able to work 
would affect plans for the future in some form and that AIP affects career and family 
planning has been reported by others (20). 
How this is handled depends on the social context as well as on personality and the 
way risk and the threat presented by AIP is perceived. The findings of paper I fit with 
the concept that illness perception and coping with illness is a process, as presented in 
the CSM of illness perception. This is illustrated by the finding that the participants 
perceived that their current knowledge about AIP was sufficient but that they expected 
this to change if their situation in life changed. It is unclear why active AIP was 
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perceived as incompatible with the ability to work, which raised the question about 
whether this perception is a realistic and accurate view of the possible future 
consequences. The literature defines recurrent AIP attacks as four or more attacks per 
year (10). Only 3–5% of persons with manifest AIP fall into this category, which 
means that most persons with AIP will be able to keep a job, even if they develop 
manifest disease. By contrast, a study from Sweden showed that one-fifth of the 
subjects with AIP reported receiving disability pension, but the authors warned that 
these figures might not be appropriate in the present because it was easier to obtain 
approval for the disability pension in previous years (22). 
There is evidence to suggest that how relatives experience a particular disease 
influences personal risk perception, coping with, and adjustment to, that disease (77). 
That the young participants who described a fear of developing manifest AIP had 
relatives with poor health and that their health problems seemed to be attributed 
exclusively to AIP might explain their expectations that active AIP has very serious 
consequences in terms of living a normal life. It has been estimated that around 20 % 
of those receiving bad news in regards to genetic testing will develop symptoms of 
stress response syndrome, although these numbers refer to genetic testing for serious 
disease (78). What constitutes “serious” disease is however subject to discussion, and 
illness perception and individual perception of risk are also factors here, but AIP can 
be potentially life-threatening. This also supports the concept mentioned above that a 
clear definition of what health problems can, and cannot, be caused by AIP is 
important to both the person experiencing symptoms and their at-risk relatives who opt 
to have predictive testing to learn about their potential risk of developing AIP. 
The finding that genetic testing and carrier status did not have a large psychosocial 
impact on the participants may not necessarily extend to other persons or participants. 
This illustrates what Thorne says is probable truth in qualitative research. Researchers 
must remain humble in view of what can be known about a phenomenon (56). 
However, this does not change the experiences reported by participants in this study. 
Without claiming that these experiences are the same for all persons with an AIP 
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mutation, they do provide suggestions for possible ways of handling the challenges of 
AIP. 
It was clear that, also for the participant who were anxious about the development of 
manifest AIP, knowing their risk of AIP did not change their plans for the future or 
cause them to take precautions. The results of paper I showing that the psychosocial 
impact of predictive genetic testing was quite small are consistent with a recent 
systematic review article that concluded that there was little evidence of harmful 
psychological consequences of genetic testing and providing such information to 
children. However, there is a lack of data on the subject, and clinical caution is still 
warranted (79). 
7.1.3 Papers II and III: PCT 
The present research shows that PCT is not always unproblematic and that it can have 
implications because of both the severe symptoms and the patients’ perception of the 
illness. For instance, compared with melanoma patients, persons with active PCT 
scored higher on consequences, timeline and identity, and higher or equal on the 
emotional response item on the BIPQ (80). The biomedical view of PCT is that it is a 
disease with good prognosis that is easily managed and treated, but at the same time 
there is also a focus on potential late complications such as diabetes, cirrhosis and liver 
cancer (81, 82). This could explain the association between illness perception and 
psychological distress. Some PCT patients worry about late complications of PCT and 
whether or not they take the necessary precautions. However, although there was a 
significant association between illness perception and psychological distress, the 
direction of this association is uncertain and the design of the study did not allow for 
conclusions about causality. 
Whether PCT is a distress-causing life event is debatable. Paper II showed that PCT 
may have a large psychosocial impact on some patients and a smaller impact on 
others. We therefore wanted to investigate the levels of distress reported by the 
participants and to identify those factors associated with higher levels of porphyria-
related distress. We found that 20% scored 0 on the Intrusion subscale and 27% scored 
0 on the Avoidance subscale of the IES. This was not surprising, as we expected many 
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participants to report PCT as not a distress-causing condition. Perhaps further analyses 
of those reporting no psychological distress could have provided important 
information, but we did do a logistic regression analysis to identify the variables 
associated with scoring > 0 on the IES and this confirmed that illness perception and 
total subjective health complaints were significantly associated with a score >0. 
Another aspect that could have yielded interesting information was to identify the 
participants who reached a clinically significant level of distress. By using cut-off 
values, the individuals whose scores on the IES suggested a cause for clinical concern 
could be identified. Various cut-off values have been suggested (49, 83, 84), but they 
do not seem to be used much and it is unclear whether these are useful in clinical 
settings. How to identify PCT patients with clinically significant levels of 
psychological distress must therefore probably rely on the clinicians expertise and 
experience, but a study from 2004 has shown that dermatologists recognize depression 
and anxiety disorders in only 33% of outpatients (85) and that psychiatric disorders 
frequently go undetected in dermatology clinical practice (23, 86). 
In study III, illness perception and higher scores for SHCs were significantly 
associated with higher distress scores. One could debate whether the emotional 
representations of PCT measured by BIPQ are closely related to the construct of 
porphyria-related distress and that this can partly explain the significant association 
between the BIPQ and IES. The literature claims that elements of fear, anger and 
distress are incorporated into the emotional representation of illness (40), although 
claims that they are representations of avoidant and intrusive thoughts are speculative. 
This was also one of the arguments for using the total illness threat measured as a 
variable in the multiple linear regression models. The total sum includes measures of 
both emotional and cognitive representations of illness and is a measure of how 
threatening the illness in question is perceived (40). 
That those reporting higher perceived threat by PCT would report more psychological 
distress was expected. However, it was surprising that reporting more health 
complaints was associated with greater distress. There is little reason to suspect that 
persons with PCT should report higher or lower prevalence or severity of SHCs than 
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the population at large, except that PCT usually presents at a mature age and is 
associated with liver disease and certain lifestyle factors, such as alcohol and smoking 
(87), factors that are known to affect health. In paper II, the participants did discuss 
their suspicion that PCT caused health complaints other than skin manifestations, and 
there was a tendency to attribute a variety of health complaints to PCT. SHCs occur in 
more than 75% of the Norwegian population when assessed over a 1-month period 
(88), and it has been suggested that SHCs are relatively stable in the population but 
that factors such as illness perception and workload may affect the reported prevalence 
and severity of SHCs (89). This raises the question about whether the observation that 
the total burden of health complaints is associated with porphyria-related distress is 
connected to the experience of PCT as a systemic condition. That is, the more health 
complaints a patient reports and experiences, the greater the distress because the 
patient assumes and perceives these SHCs as directly related or somehow connected to 
PCT. According to the CSM, the perceived cause of disease can be split into internal 
and external causes (46). Whether PCT is caused by internal or external factors is an 
interesting question. In Norway, about 50% of PCT cases are associated with a 
mutation in the UROD gene and can be classified as fPCT (16). However, because of 
the low penetrance of 10% and the fact that PCT also occurs in a sporadic and non-
inheritable way, it is perhaps not biomedically correct to denote PCT as condition 
caused exclusively by internal or external factors. Although sunlight is a necessary and 
obligatory factor for developing symptoms of PCT, sunlight does not in itself cause the 
excess hepatic production of porphyrins. This refers back to the philosophical question 
of what illness is. According to the BPS model, the difference between being well and 
sick is not merely the result of biological factors but will always be influenced by 
culture, social, psychological and/or environmental aspects (42). 
The qualitative focus group study showed that PCT is perceived as something more 
than an uncomplicated skin disease. We found this interesting and felt that it indicates 
the need to assess the perception of PCT by persons living with this condition in the 
active, remission and latent phases. The results reported in paper II showed that PCT 
was perceived as a chronic condition requiring follow-up, controls and prophylactic 
treatment, and that some patients found it necessary to attend very frequent controls. 
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PCT was suspected to cause a range of symptoms and health complaints. The results 
reported in paper III confirmed that PCT is perceived as a chronic and lifelong disease 
despite its good prognosis and likelihood of full remission. But why do patients in 
remission, who no longer need treatment, report psychological distress? Is it the 
uncertainty of new relapses? In view of the results showing that the total health 
complaints were associated with porphyria-related distress and the results in paper II 
showing that some PCT patients have a tendency to attribute just about any health 
complaint to PCT, a possible explanation is that health complaints other than skin 
symptoms are considered to be caused by PCT and this then contributes to patients 
reporting greater psychological distress. An alternative explanation is that the 
possibility of confusing other health complaints with PCT symptoms results in a 
“false” self-reported classification of the participant’s current status into active, 
remission or a latent phase of PCT.  
The participants in paper III reported having a high understanding of PCT, but does 
this give an accurate picture? According to the CSM, individuals’ beliefs about their 
condition will be influenced by personal experience and information from health 
professionals, media and other people, and might not be accurate in the biomedical 
sense (47). PCT is frequently associated with other diseases (alcoholism, hepatitis and 
others), but we did not collect data about these diseases, which can modify illness 
perception and health complaints. On the other hand, both the BIPQ and IES were 
porphyria specific as used in this research, and the answers provided here may pertain 
only to PCT. However, the findings included in papers II and III suggest that it can be 
difficult to separate PCT from other conditions and other health complaints. This is 
important to keep in mind when interpreting the results. Associated diseases and 
lifestyle factors are highly relevant and should be considered when treating and 
counselling this patient group. 
Although itching in PCT patients was a symptom reported by 24 % of participants in a 
previous study (82), this is a symptom that is rarely mentioned in regards to PCT and it 
came as a surprise that itching was perceived as the most problematic symptom for 
some participants in study II. However, one cannot draw any conclusion as to whether 
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it is the accumulated porphyrin level in the skin that causes the itching or even whether 
PCT patients experience more itching than the normal population, although we can 
conclude that itching is experienced as a considerable problem for some patients and 
that it is very likely to cause problems such as delayed skin healing, additional skin 
ruptures and possibly skin infections in patients with clinical PCT. To investigate this 
further, the NPR introduced this variable in their questionnaire. Recent results from the 
NPR (unpublished data) show that itching was one of the most frequent symptoms 
reported by PCT patients experiencing clinical relapse. Itching is also associated with 
reduced QoL (90) and should not be underestimated. During clinical consultations, 
itching should therefore be identified and addressed appropriately. 
Participants in the focus group study noted that phlebotomy treatment caused rapid 
improvement and contributed to making the diagnosis less dramatic. The results of 
paper III confirmed that PCT was perceived as a condition with high personal and 
treatment control.  
The time since the diagnosis and symptom activity may be associated with 
psychological distress related to porphyria. A meta-analysis of 66 studies that used the 
IES to measure the psychological impact of specific life events found that only a small 
proportion of scores could be attributable to age, gender or cultural differences, 
whereas the type of event and time elapsed since the event were strong predictors of 
stress levels (50). That we did not use the time since the last experience of symptoms 
or diagnosis as an IV in the multiple linear regression analysis could be considered a 
weakness in the design. By contrast, symptom activity was not significantly associated 
with distress, which would be an expected association if the time since diagnosis was a 
relevant factor.  
A significant gender difference in clinical presentation of PCT was reported by 
Munoz- Santos et al (82). They found that women had more facial hypertrichosis, 
pruritus and involvement of skin areas other than hands and face. Gender differences 
in the perception and experience of symptoms such as hypertrichosis were discussed 
but were rejected by the focus groups. Paper III also concluded that gender was not 
significantly associated with porphyria-related distress. 
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7.2 Methodological considerations 
When considering the methodological aspects, the two qualitative papers (papers I and 
II) can be evaluated in view of the criteria and considerations appropriate for 
qualitative studies using an ID approach. In this section, the methodological aspects of 
papers I and II are evaluated and discussed together. Paper III and the quantitative 
approach used are discussed separately and in the context of the criteria appropriate for 
this approach. A short discussion of mixing methods follows. 
7.2.1 Credibility in the qualitative studies (Papers I and II) 
Quality in qualitative health research is a complex and ongoing topic of discussion. 
However, according to ID, there are four main criteria for judging the quality of the 
qualitative research process: epistemological integrity, representative credibility,
analytic logic and interpretive authority (56, p 101, 223-226). In this thesis, these four 
key criteria were used as a point of exit for the methodological discussions about 
papers I and II. 
Epistemological integrity refers to the coherence that is necessary between stated 
epistemological assumptions and the chosen research design; i.e., the research question 
and the interpretation of data and analytical strategies must be consistent with the 
epistemological standpoint of ID. According to ID, “the truth” will always be 
complex, contextual, constructed and ultimately subjective (54). This implies that one 
can never know the absolute truth but can still value knowledge as the probable truth, 
which is the best we have so far (56). Our research question focused on exploring the 
experiences of individuals who had been predictively tested for AIP as minors and the 
experiences of persons with PCT, and as such aimed at producing knowledge that was 
relevant for practice with potential applications to the counselling of porphyria 
patients. This is consistent with the stated aim that, ideally, the results of an ID should 
have practice implications (56) without assuming that the knowledge revealed is true 
for all AIP and PCT patients. If anything, the results presented show that the 
participants’ experiences varied and that the individual patients’ perceptions and 
experiences should be taken into consideration in clinical consultations. That the 
analytic strategies chosen for interpreting the data sources must be consistent with the 
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epistemological assumptions in ID means that the use of STC as an analytical 
inspiration must be in agreement with the fundamental principles of ID. For instance, 
both ID and STC claim that data collection and analysis should be performed 
simultaneously so that a constant comparative approach can be achieved. Although 
simultaneous data collection and formal data analysis were not conducted in either 
paper I or II, there was a conscious effort to follow up the findings in successive 
interviews and focus groups. In this sense, we argue that a degree of informal analysis 
was performed and that the fundamental principles of constant comparative method 
were met. 
To achieve representative credibility, the sampling procedures must be in agreement 
with the results claimed to have been found (56, p 224). When recruiting participants 
to the study described in paper I, we chose a sampling strategy to explore the 
experiences of persons who had been predictively tested as minors, but at the same 
time we wanted them to be old enough to have reflected on the experience. Using this 
rationale, we chose to include persons between the ages of 16 and 21 years. This can 
be viewed as an arbitrary choice of age and, although our intent was that this sample 
could provide the information of interest, we cannot know whether participants 
younger than 16 years or older than 21 years would have provided different but 
valuable information. For this reason, we also kept the option open to expand the 
inclusion criteria if necessary. 
One of the results of the study was that AIP was a small part of the participants’ 
identity. In hindsight, it is possible that a larger number of participants could have 
revealed other experiences. That AIP was not a large part of the participants’ lives also 
meant that the interviews did not provide the very rich information one may have 
wished for. On the other hand, this could also be viewed as a finding in itself, which is 
our conclusion based on the fact that this was an impression given in all 10 interviews. 
In ID, what is considered an appropriate sample size will always be debatable and 
there is no objective justification for a specific number. Relying on “saturation” is 
problematic because health research can never claim to have obtained sufficient data to 
cover all possible relevant understandings of the clinical phenomena in question (56, p 
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97-98). Also in STC, the concept of “saturation” is deemed impossible to achieve and 
is not a goal for data collection (62). The term “information power” has been proposed 
as a more suitable guidance for judging sample size in qualitative studies (91). 
When considering the sampling procedures in study II, the approach of recruiting only 
participants from a patient seminar requires careful reflection in terms of how the 
specific context may have provided a sample that is different from the more general 
population of PCT patients. It is not unlikely that the participants at the seminar were 
especially interested, preoccupied or perhaps “threatened” by their PCT diagnosis, 
whereas others with a different illness perception may not have been represented. In 
this perspective, some form of methodological triangulation is valuable and can help 
find what Thorne refers to as “substantive completeness” (56, p 224). One way of 
doing this was to design study III to challenge several aspects of the findings of study 
II. However, this does not mean that the findings from each study cannot stand alone 
or provide important knowledge for clinical practice. 
Analytic logic may be understood in terms of the claim of transparency in the research 
process and a need for explicit reasoning from the fore-structure through to 
interpretations and claimed results. Thorne (2008, p 225) suggests the use of an audit 
trail, which is a description of the pathway of decision making throughout the research 
process, so that another researcher can follow this. There is seldom allowed sufficient 
room for this in the traditional limitations of a research article and is therefore the 
analytical steps taken are presented more explicitly in the material and methods 
sections of this thesis. By referring to analytical approaches such as the use of STC, 
the process of transparency can be aided in the limited space that is usually available 
in published articles with strict word limits. Analytical decisions were discussed with 
co-authors (supervisors) to aid the reflexive process, thus making the analytic logic 
more transparent. 
The analytic process in qualitative research is always influenced by the researcher’s 
point of view and contains an element of interpretation; at the same time, there needs 
to be assurance that the researcher’s interpretations are trustworthy. This is what 
Thorne calls interpretive authority. Sufficient information must be provided about the 
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data that form the basis of the results and interpretations, and the background and 
intentions of the researcher (56, p 225). The researcher consequently needs to be overt 
about the background and perspective upon which the interpretations are based. The 
researcher’s background and pre-understanding should be presented. In papers I and II, 
this was possible to only a limited degree, but providing a personal preface to this 
thesis has hopefully provided an important backdrop for the reader to judge more 
easily the credibility of the results. This is even more important when the researcher, 
as is the case in this thesis, is working closely with the study population. 
Ideally, one should not interview one’s own patients because the participant may wish 
to please the clinician, or in this case, the genetic counsellor, and try to give answers 
he or she thinks the interviewer wants to hear (58). This might have been especially 
relevant in this research because the participants were young, had relatively little 
experience with AIP, and AIP was only a small part of their identity. That the 
participants wanted to provide “the right” answers was an impression formed during 
the interview process, although it is difficult to differentiate between whether this was 
because of the participants’ young age or their wish to seem well informed regarding 
AIP (or both). During the interviews a conscious effort was made to not let the 
participants feel that they were “tested” in any way. There is a possible power 
imbalance in that the researcher was both the person performing the research 
interviews and the person the participants would contact if in need of counselling 
about AIP. For instance, in paper I, one participant had received GC from the 
interviewer before the interview. 
It is also important to provide sufficient contextual information about the participants, 
the interview situation and the topics of the interviews. We aimed to provide this 
through the presentations of the participants and the themes of the interview guide in 
the articles. This gave rise to a potential problem in protecting the participants’ 
anonymity because their pseudonyms and personal information could be connected to 
the quotes presented. This was discussed, but the need to contextualize the quotes and 
provide background information was deemed important in terms of the research 
credibility and for making sense of the results. 
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7.2.2 Validity and reliability in the quantitative study (paper III) 
In the following discussion of the PRO instruments used in the present study, the 
COSMIN definitions of measurement properties were used as point of exit. COSMIN 
stands for COsensus-based Standards for the selection of health Measurement 
INstruments, and provides the standard criteria developed for evaluating measurement 
properties (67). The quality of a measurement instrument is based on three criteria: 
validity, reliability and responsiveness (92). Responsiveness is the ability of an 
instrument to detect change over time in the construct being measured (63). Because 
we used a cross-sectional design (paper III) not intended to assess change over time, 
responsiveness is not discussed in further detail. 
Reliability refers to “the degree to which the measurement instrument is free from 
measurement error” (63, p 96) and to what extend scores for un-changed patients are 
the same for repeated measures (92). This quality domain contains three measurement 
properties: internal consistency, reliability and measurement error (92). The 
instruments used in paper III were all found to have satisfactory reliability (40, 52, 72), 
and only internal consistency in relation to the use of a total sum score on the BIPQ 
will be discussed further.  
Internal consistency is defined as the degree of interrelatedness among items on a scale 
(67), and is a measure of to what degree the items measure the same construct. It does 
not, however, say anything about what this construct is (63). The BIPQ is intended 
mainly as a single-item measure but can also be used to assess how the total threat of 
an illness is perceived, provided that the internal consistency is considered appropriate 
for the sample in question (40). 
We chose to use Cronbach’s alpha to assess the internal consistency. The acceptable 
value frequently used for this coefficient is between 0.70 and 0.90 (63), while others 
refer to a cut off of at least 0.60 but preferably 0.70 or higher (93). One might argue 
that a Cronbach’s alpha of 0.67 is low in relation to the choice of using the BIPQ as a 
total score in the multiple linear regression analysis. There is also some controversy 
about the use of Cronbach’s alpha as a measure of internal consistency in assessing 
PRO. Some researchers contend that this is not a very reliable measure (68), whereas 
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others argue that Cronbach’s alpha is a valid measure of internal consistency (63). One 
of the criticisms of Cronbach’s alpha as a measure of internal consistency is that the 
coefficient value is highly dependent on the number of items and a low number of 
items will usually give a lower value (63). Because Cronbach’s alpha is the best-
known parameter for assessing internal consistency, we chose to use the BIPQ total 
score in the multiple linear regression analysis. 
Validity refers to the degree the instrument measures the construct it says it measures. 
There are three properties of this: content validity, construct validity and criterion
validity (92).   
Content validity refers to whether the instrument’s items reflect the construct the 
instrument is supposed to measure. There are several aspects to be considered when 
evaluating content validity, such as whether the instrument is comprehensive and 
relevant (92). It is worth considering whether relevance was a problem with our use of 
the IES because we observed a floor effect. About 25% of the respondents scored 0 on 
this measurement, and this could be interpreted to mean that the instrument was not 
relevant for this population. On the other hand, Horowitz and colleagues (41), and later 
authors (49, 50, 52) have concluded that the IES is an effective measure of subjective 
psychological distress relating to any life event, and as such, should be relevant for any
population if one does not have the appropriate knowledge on how the “event”, in this 
case PCT, impacts those inflicted. Paper II provided strong indications that for some, 
PCT seemed to have a large psychosocial impact. Because we expected that PCT 
would cause little or no distress for many (the floor effect), it is not surprising that a 
large proportion scored a total of 0 on the IES. The floor effect is not uncommon when 
using an existing instrument on new populations but is more problematic in 
longitudinal studies in which it may affect the responsiveness of the instrument (63, p 
233). 
Content validity also involves face validity, or whether the instrument appears to 
reflect the construct being measured. What is acceptable face validity is not subjective 
to set standards but is based on subjective evaluation. Comprehensiveness and 
relevance can be evaluated by experts and the patient population it is intended for (92). 
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The total questionnaire was therefore piloted on a group of “experts” who were 
persons working at NAPOS who had extensive experience with both porphyria and the 
research process. The feedback we received was that the questionnaire was generally 
comprehensible and easy to answer; the main negative comment was that the total 
questionnaire was long and took 20–45 minutes to answer. This was an element to 
consider since only three instruments are used in the present thesis. That said, the total 
data material has also resulted in two master theses (94, 95) and will hopefully also 
result in the publication of an article on illness perception among people with AIP.  
There was no pilot study applied to the patients and this was a criticism made by one 
of the two porphyria patient organizations in Norway, which mentioned this in their 
annual membership magazine and encouraged patients uncomfortable with the 
questionnaire to not reply or to withdraw previous returned questionnaires (96). In 
retrospect, we do regret this, but because we did not use any instruments that were 
made specifically for the present studies, there were limited opportunities to alter the 
wording. Before the study began, both the overall aim of the study and the recruitment 
procedures were discussed with representatives of the same patient organization and 
they did not have any remarks about the forthcoming study. It can be debated that this 
might have affected both the representativeness and generalizability of the study by 
reducing the total number of respondents or by causing a selection bias, in addition to 
compromising the content validity by not testing the questionnaire on actual patients. 
However, we did not receive any complaints or desire to withdraw from the study and 
do not have the impression that these factors affected recruitment. On the other hand, 
this might be viewed as problematic from an ethical perspective, and we regret that 
some of the representatives from the patient organization did not experience sufficient 
user involvement. 
Construct validity refers to the degree to which a measurement instrument really 
measures the construct it is intended to measure (63, p 169). Both the IES and the 
BIPQ have strong theoretical foundations and have been used throughout the research 
literature (40, 41, 47, 49, 50, 64, 97). The SHC Inventory was used in this study to 
survey the degree of self-reported health complaints the participants reported. The 
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authors refers to the 29 items comprising the questionnaire as “commonly reported 
subjective health complaints” (72) and “ a wide range of subjective health 
complaints”(88) without further explaining how the 29 items were chosen. This might 
pose a problem in regards to the five domains measured by the instrument because 
there seems to be a lack of information on how these were developed.  An essential 
feature of the inventory is however the avoidance of attempting to attribute complaints 
to diagnoses or theoretical speculations into psychological or psychosomatic factors 
(72), and as such using the total sum score of SHC might be less problematic. The 
PCT sample was not matched against the Norwegian population, and we could not say 
anything substantial about whether persons with PCT have more health complaints 
than the average population.  
Criterion validity is important in regards to the study’s external validity. The term 
criterion validity is defined as “the degree to which the scores of a measurement 
instrument are an adequate reflection of a gold standard” (67). This is understood in 
terms of measures of objective standards, such as measurement of height and weight. 
One aspect that might contain an element of criterion validity in paper III is the 
categorization of the participants’ condition into latent, remission and active PCT 
using self-report. As mentioned in paper III, it is possible that the patients confused 
other health complaints with PCT symptoms, and this may have affected the 
classification into latent, remission and active PCT. One possibility could have been to 
collect a urine specimen together with the questionnaires, for analysis of porphyrin 
excretion levels. This could have provided important information regarding 
biochemical status, although there are individual variations in the level of porphyrin 
excretion that leads to the development of symptoms. Such urinalyses could therefore 
also have proved difficult to interpret in regards to clinical status and the classification 
of participants. Another aspect of the categorization into active, remission and latent 
phases being based on self-report is that those in the latent PCT group are assumed to 
have been predictively tested for a known UROD mutation in their family, but this 
cannot be guaranteed. 
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In future, inclusion of objective measures may help prevent the possibility of “false” 
self-classification. The use of instruments specific to dermatology should also be 
considered. In the present thesis, our aim was not to investigate QoL. However, there 
is a shortage of research on QoL in people with PCT, and instruments such as the 
Skindex or the Dermatology Life Questionnaire Index (DLQI) could be relevant 
measures, preferably in combination with a generic QoL instrument such as the World 
Health Organization QoL instrument (WHOQOL) (98). On the other hand we used 
instruments specific to the condition; that is, both the IES and the BIPQ were made 
porphyria specific. 
Another important aspect in regards to external validity is representativeness. Selection 
bias should always be considered because it can affect the generalizability of results. 
The fact that we excluded those with no known UROD mutation and no available 
samples for control of their PCT during the past 10 years could be considered 
problematic in this regard. Although this did not comprise a large number of persons 
(n = 34), it may have created a selection bias. The mailing of the questionnaires in 
May, June and October may have affected the results because this is the “high season” 
for PCT symptoms. This should be considered, and might have yielded a larger 
proportion of persons with active PCT in our sample. We did not include any analysis 
of the 186 non-responders, but they comprised about the same number of women (n = 
82) and men (n = 104), and most were older than 50 years (n = 143). 
Another potential problem in regards to generalizability was the response rate. 
However, we argue that a response rate above 50% is generally considered satisfactory 
and average response rate in studies utilizing data from individuals is estimated to 
52.7% (99). 
When discussing validity and reliability in quantitative research, one must consider 
both the instrument properties and the suitability of the chosen design and analytical 
approach. Because about 25% of the participants scored 0 on the IES, many 
participants were eliminated from the multiple linear regression analysis. The rule of 
thumb for sample size is 15 participants per independent variable (IV) or n >50 plus an 
additional eight cases per IV. More cases are needed if the data are skewed (100). 
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Because we included a total of five IVs, we would need a minimum of ≥90 plus 
additional cases for skewed data. We believe that our sample size fulfils these rules 
because we had a total of 263 cases eligible for analyses, minus those scoring 0 on the 
IES subscales, which yielded a total of 185 subjects for the analysis of intrusion and 
168 for avoidance in the multiple linear regression analysis (Table III, paper III). 
Although the number of eligible participants with active PCT was low, we used the 
dichotomized variable active/not active PCT as an IV in the regression analysis, and 
the total number of cases was satisfactory. Thus, we do not believe that this represents 
a problem. 
7.2.3 Mixing methods 
Whether the scientific approach in this thesis should be called a “triangulation of 
methods”, “mixed-method” or “multiple-method” research design will vary between 
individual researchers. When planning the design of the present thesis, several senior 
researchers warned against mixing methods; not because one or the other paradigmatic 
approach was considered “wrong”, but simply that mixing the two was considered 
unfeasible or that it would not be possible to attain the necessary skills and 
competence to manage both appropriately. A dispute between researchers taking a 
quantitative purist stance on social science and those advocating a qualitative purist 
view has resulted in what has been termed a “paradigmatic war” and the 
“incompatibility thesis”, which claim that qualitative and quantitative methods cannot 
and should not be mixed (101). The philosophy of using mixed research is an attempt 
to take multiple viewpoints and perspectives, and a pragmatic approach to knowledge 
(102), which was also the viewpoint of the present thesis. Also, Thorne noted that ID 
is especially suited for a “mixed standpoint” (56, p 224).  
It is also believed that learning and teaching epistemological and methodological 
pluralism provide a better understanding of the methodological possibilities available 
and thus promote collaboration, which is necessary in an increasingly more complex 
and interdisciplinary research reality (101). This is especially important in the world of 
the porphyrias (and other conditions), where the social sciences meet a strong 
positivist culture of research. The viewpoint in this thesis is that mixing paradigms can 
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be an advantage and is in agreement with Johnson and Onwuegbuzie that mixed 
methods constitute “ a research paradigm whose time has come” (101). Taking a 
“mixed position” has allowed for a broader understanding of the challenges met by 
persons with AIP and PCT, and has provided empirical findings that complement and 
elaborate each other. 
On the other hand, the question of being able to attain, in a restricted time period, the 
necessary competency to manage appropriate and high-quality research is a valid one. 
Hopefully, this is feasible, and may be especially relevant in light of qualitative 
approaches such as ID, which emphasize the educational and applicable background in 
the health sciences by explicitly drawing on an eclectic and pragmatic approach to 
knowledge (56). 
When defining what constitutes a mixed-methods design, one of the many issues 
debated is the stage at which the mixing occurs. Although there is general agreement 
that the mixing can occur at all stages of the research process (102), others are clear 
that the use of the term “mixed methods” demands the inclusion of an additional and 
supplemental analytical strategy that contains a component that cannot stand alone; 
that is, the mixing of methods must be within one study and published as a complete 
project (53). We used separate and individual empirical parts that can stand alone 
while also complement and build upon each other to answer the overall aim. Thus, we 
opted to take the safe stance by defining this thesis as a multiple-method research 
approach, in which multiple methods are defined as “two or more complete projects 
attached to an overall inductive aim. The research questions for each study are 
separate, but complementary to the overall aim” (53). 
CONCLUSIONS AND IMPLICATIONS FOR PRACTICE 
Predictive testing for AIP entailed few psychosocial consequences, but the results 
indicate the potential for increased patient anxiety even without necessarily generating 
lifestyle changes. The ethical implications and clinical caution need to be considered 
when predictive genetic testing is performed on minors. Recent clinical research 
advocates caution, although there is little evidence of psychological harm to minors 
who undergo genetic testing (79). Appropriate counselling and informed consent are 
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advisable and are mandatory in Norway; this is a judicially sound decision that is 
supported by the results of this thesis and other studies, in addition to international 
ethical guidelines (32, 33). 
At their worst, PCT symptoms can be dramatic. Itching must be taken seriously. 
Participants had a perception of PCT as a systemic condition and a tendency to 
attribute a range of health problems to the condition. This could lead to improved 
compliance with treatment and regular follow-ups and controls, but also 
medicalization and overtreatment. This finding suggests a need for information and 
reassurance in clinical consultations. During the clinical consultation with these 
patients, it is important to discuss the patient’s perceptions of the illness and to 
consider the total burden of health complaints and psychological distress. Patients with 
a high perceived illness threat and multiple health complaints might be especially 
vulnerable to psychological distress related to PCT, and clinicians should be attentive 
to the totality of each patient’s situation. 
 FUTURE PERSPECTIVES 
This thesis has shed some light on the experiences and challenges faced by persons 
with AIP and PCT. Further research is warranted. According to paper I, it is 
reasonable to question whether psychological distress about AIP is more closely 
associated with perceptions about the illness than with AIP symptom activity. Data 
have already been collected for a follow-up study to describe the perceptions of illness 
and psychological distress in AIP patients, and to identify the factors associated with 
distress in this group. Further investigations of the health-related challenges and QoL 
in adults with AIP experience are also of interest, and qualitative and explorative 
studies are recommended. The patients themselves have recommended the need for 
further research into the experiences of people living with porphyria (4). 
As far as we are aware of, no large-scale QoL studies of  PCT patients are performed, 
and the use of dermatology-specific instruments such as Skindex or DLQI, combined 
with a generic QoL measurement such as the WHOQOL-Brief (98) could yield 
interesting information. Such studies should also take into account the time since 
diagnosis and symptoms. A longitudinal study that used dermatology-specific 
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instruments with a high degree of responsiveness will be suitable for detecting changes 
over time (63) and could be distributed to newly diagnosed patients and followed up 
throughout treatment and long-term remission. This could be helpful in identifying the 
vulnerable periods of time for this patient group. Also register-based research (NPR) 
will be important in order to investigate QoL in PCT patients. Qualitative research that 
focuses on patients in remission could provide a better understanding of why PCT 
patients experience the condition as something requiring frequent follow-up and 
prophylactic treatment, and whether this is problematic.  
NAPOS offers predictive genetic testing and counselling, and an evaluation of the 
benefits and effectiveness of these would provide important information. The results of 
the present thesis indicate that clear and concise information about AIP and PCT for 
patients is lacking. A clearer definition of what constitutes an AIP attack is needed. 
New register-based research, both national and international (NPR and EPR), will 
hopefully aid in this process and provide information about the psychosocial 
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Summary
Background Porphyria cutanea tarda (PCT) is characterized by fragile skin with blis-
tering on sun-exposed areas. Symptoms typically develop in late adulthood and
can be triggered by iron overload, alcohol intake, oestrogens and various liver
diseases. Treatment consists of phlebotomy to reduce iron, or increasing urinary
porphyrin excretion by administering chlorochin. To optimize patient care,
health personnel need to understand the subjective experiences of PCT.
Objectives To explore the experiences of persons with PCT with regard to symp-
toms, treatment, follow-up and prevention of the disease.
Methods Interpretive description was used as a qualitative approach. Twenty-one
participants attended three focus groups. All participants had experienced PCT
symptoms during the last 5 years.
Results Participants’ experiences varied from trivializing symptoms and fragile skin
to what was described as a desperate situation, with huge blisters, skin falling off
and feeling as if one was in a ‘horror movie’. For some, itching was very trou-
blesome, preventing sleep and delaying skin healing. In managing PCT a shift in
focus from skin to blood was described. PCT was perceived as a chronic and sys-
temic disease causing a range of health problems. Strategies for preventing symp-
toms ranged from doing nothing to frequent controls and check-ups.
Conclusions Participants had a systemic perception of PCT, and a tendency to attri-
bute a range of health problems to the condition. This study adds insight into
the experiences patients have with PCT.
What’s already known about this topic?
• Photodermatoses can have a profound impact on quality of life, but little is known
of the subjective experiences of porphyria cutanea tarda (PCT).
What does this study add?
• Participants’ symptoms varied from fragile skin to what was described as a desper-
ate situation.
• Participants had a systemic perception of PCT and a tendency to attribute a range
of health problems to the condition.
• Itching was reported to be a severe problem for some participants.
Porphyria cutanea tarda (PCT) is a rare disease characterized
by fragile skin and blistering on sun-exposed areas. Increased
urinary porphyrin excretion causes red- or dark-coloured urine.
Symptoms typically develop in late adulthood and can be
triggered by hepatic iron overload, alcohol intake, oestro-
gens, hepatitis C and various liver stressors, in combination
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with exposure to light. The prevalence of symptomatic dis-
ease is estimated to be 1 in 10 000.1,2 The condition exists
in both a familial and sporadic subtype. Compared with
25% of cases worldwide, about 50% of cases of PCT in
Norway are hereditary because of two founder mutations.3,4
Penetrance is very low, and only an estimated 10% of
mutation carriers develop symptoms throughout life. Treat-
ment consists of avoidance of precipitating factors, phlebot-
omy to reduce iron or increasing urinary porphyrin
excretion by administering chloroquine.4
It might take 6–15 months before complete clinical and
biochemical remission is reached,5,6 but the prognosis is
good, and many patients experience lifelong remission. To
detect relapse, urinary porphyrin concentration, iron and liver
functions should be assessed annually.4,7
The principal aim of the Norwegian Porphyria Centre is to
optimize the diagnosis, treatment and follow-up of patients
with porphyria. Although the clinical benefits of mutation
screening are controversial,4 distinguishing between sporadic
and familial cases appears to be important to many patients
and their relatives,3 and NAPOS therefore offers, in hereditary
cases, predictive genetic testing and counselling to at-risk adult
family members.
Photodermatoses can have a high psychological impact.8
Jong et al.9 investigated quality of life (QoL) in patients
with a range of photodermatoses, including PCT. They con-
cluded that, overall, photodermatoses had a major impact
on QoL, but that PCT had a lower impact on QoL than did
other cutaneous porphyrias. Very little knowledge of the
psychosocial impact of PCT is available and more informa-
tion on the subjective experiences is therefore needed to
secure optimal treatment, follow-up and counselling of this
group. The aim of the present study was therefore to
explore the experiences persons with PCT have regarding
symptoms, treatment, follow-up and prevention of the dis-
ease.
Methods
This study was based on interpretive description, which is a
well-documented qualitative approach with emphasis on clini-
cal practice and exploration of health-related issues.10–12 Focus
groups with interactive discussions were deemed appropri-
ate.13 The study complied with the principles of the Declara-
tion of Helsinki and was approved by the Norwegian regional
ethics committee (2012/1078).
Recruitment
A convenience sample was recruited in connection with a
biennial patient seminar arranged by NAPOS in 2012.12
Information regarding the focus groups was included with
invitations to the seminar. Experience with symptoms dur-
ing the last 5 years was set as the inclusion criterion.
Forty-six people with PCT participated at the seminar and
23 provided written consent to participate in the focus
groups. Two were excluded because of clinical remission
exceeding 5 years.
Data production and participants
The patient seminar consisted of joint sessions and lectures
on symptoms and treatment, in addition to conversation
groups for patients to share their experiences. Three focus
groups with seven participants were held over two consecu-
tive days at the seminar.14 In light of the rich information
provided, the sample size was deemed satisfactory.12 The
interviews lasted approximately 90 min. The participants
included 11 women and 10 men, aged 31–77 years. Three
participants reported having haemochromatosis (Table 1).
The interviews were moderated by the first author (J.A.),
who is experienced in counselling patients with porphyria.
One co-moderator participated in the first two groups while
a second participated in the third group. The interviews were
semistructured and focused on three main themes with sub-
questions. The main themes of the interview guide were: (i)
experience with symptoms; (ii) treatment; and (iii) future
expectations. Emerging themes that were not addressed by
the interview guide were followed up in consecutive
interviews.
Analysis
Analysis was performed in accordance with interpretive
descriptive guidelines and was also influenced by systematic
text condensation.11,12,15 Analysis was primarily performed
by the first author (J.A.), with discussions and guidance
from the other authors (E.G., S.S. and M.R.). Audio record-
ings of the interviews were transcribed verbatim and ini-
tially read as a whole. In the first step, focus was on
reflections and main impressions and four preliminary
themes were identified: (i) large variations in symptom
experience; (ii) taking control; (iii) treatment; and (iv) pre-
vention of symptoms. In step two, coding and text conden-
sation were performed based on these themes, while special
attention was given to avoidance of premature closure of
coding.12 Coding was first conducted cross-case, followed
by longitudinal coding at an individual level.15 In step
three, coding was elaborated with subgroups and further
text condensation. Step four was an iterative process where
focus shifted from the decontextualized codes and the tran-
scripts as a whole; based on this, a synthesis of the coded
material was presented as three main themes with sub-
themes. For validation, the full transcripts were re-read
several times and systematically searched for data that chal-
lenged the results.
Results
The results are presented as three main themes with subsec-
tions. Quotes are used to elucidate and elaborate the experi-
ences of the participants. Participants are anonymized.
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Theme 1: large variations in participants’ experiences of
skin symptoms – from trivializing to nightmare
descriptions
Trivializing symptoms
Participants’ skin symptoms typically presented as small blis-
ters or very fragile skin, and simple things like putting hands
into a pocket could cause skin trauma. Slow-healing sores
were suspected by participants to have been caused by burn-
ing or cutting themselves without noticing, or from allergic
reactions to chemicals or similar incidents. Discoloured urine
was explained by drinking too little. This tendency to trivialize
PCT symptoms as being caused by ‘normal things’ resulted in
participants waiting to seek medical expertise, which contrib-
uted to a delayed diagnosis. Several persons explained that
other people’s comments about their skin made them realize
they needed to see a doctor. When they finally did, diagnosis
was often missed, especially if they were not referred to a der-
matologist. Veronica explained:
I haven’t had those really large, fluid-filled blisters. But
I had very small blisters and really fragile skin. I’ve had
to be very careful not to bump into things when it was
at its worst, because it didn’t take much, just barely
scraping with a fingernail. And it never healed; it just
itched. And also the part with the coloured urine,
because that started long before the symptoms on my
hands did.
Itching – an underestimated problem?
It became evident that itching was a problem, with some con-
sidering itching to be the worst aspect of PCT. Itching was
attributed to skin healing and seen as a sign of rising porphy-
rin levels. Participants would itch both when experiencing
symptoms and when in remission. The itching was predomi-
nant at night, and would typically start after going to bed. It
was debatable whether this was because of the warmth of the
bed, or because it was more noticeable at this time. The itch-
ing disrupted or prevented sleep, and already fragile skin was
easily ruptured, resulting in bleeding, further delaying skin
healing and increasing the probability of infection. Some slept
with gloves on to prevent inadvertently hurting themselves.
Nick said:
It itches so much [several nods in agreement], so that’s
what I feel is the biggest problem. And then you lie
awake at night and you scratch and it bleeds. Because
of this, it never heals because it is scratched too often.
. . . It is there all the time, but it is at night that I
scratch because I cannot help myself. So yes, that is
when I notice it the most. It itches all the time, but that
is when you might hurt yourself.
Table 1 Participant characteristics
Sex Age (years)
Year of elevated urinary
porphyrin levels Type of PCT HFE status
Group 1
Nick 61 2001, 2009 Sporadic Normal
Frank 59 2009 Sporadic Heterozygous H63D
John 56 2005, 2008 Familial Normal
Linda 60 2008 Sporadic Normal
Michelle 62 1998, 2009 Sporadic Normal
Nora 34 2012 Sporadic Homozygous C282Y
Alice 52 2010 Familial Normal
Group 2
Peter 67 2006 Familial Normal
Jack 56 2004, 2008 Familial Normala
Simon 57 2010 Familial Normal
David 68 2005 Sporadic Normal
Andrea 62 2006 Sporadic Heterozygous C282Ya
Lucy 66 2010 Sporadic Normal
Julie 58 2008 Sporadic Heterozygous H63D
Group 3
Tony 77 2001, 2009 Unknown Unknown
Martin 51 2009 Familial Heterozygous C282Ya
Sandra 64 2011 Familial Normal
Lilly 58 2009 Familial Normal
Monika 55 2009 Familial Heterozygous C282Y
Rachel 56 2010 Familial Heterozygous C282Y
Veronica 31 2009 Familial Normal
PCT, porphyria cutanea tarda; HFE, haemochromatosis gene. aParticipants reported having haemochromatosis.
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Skin symptoms at their worst: ‘living in a horror movie’
At its worst, PCT was painful, causing large fluid-filled blisters
that would rupture, run and cause fragile skin to fall off.
Fluids from blisters would squirt when shaking hands with
others, and one explained that she drained her blisters with
hypodermic needles. Bandaging was time-consuming and,
when removed, skin would be ripped off. Participants would
wear hats and cotton gloves to protect their skin and hide
their symptoms from others, which would result in comments
that they were ‘snobs’. One participant had to empty blister
fluids from his gloves while working. Everyday situations such
as putting on shoes could cause the skin to peel off and some-
times these areas would become infected. When the PCT
symptoms were at their worst, the situation was experienced
as dramatic and described as ‘being in a horror movie’. Lilly
said:
I was just desperate! And my grandchildren? At that
point, I didn’t know if I could touch them or give
them a hug or what, you know? It just kept running! It
was burning! . . .. So, it was a desperate situation, also
because you don’t know what it is. I was thinking, “Oh
my god! Am I going to lose the skin on my entire
body?” You know? Can no one help me?
Theme 2: a skin disease, a blood disease or something
in between?
A shift in focus from skin to blood
After their diagnosis was established, participants described
a shift in focus. One participant explained that she was sur-
prised when she understood that PCT was not a simple skin
disease. At first, PCT presented as skin symptoms, and diag-
nosis was based on patients seeking medical care for this.
However, after diagnosis was established, the focus shifted
from the skin to the blood. The use of phlebotomy as a
treatment for PCT emphasized this. Blood samples, blood
values and phlebotomy introduced a technical aspect, and
many participants displayed a keen interest. They brought
copies of their blood work to the focus groups and com-
pared and discussed who had the highest ferritin levels and
at what level they preferred to undergo prophylactic phle-
botomy. Nora said:
Yes, and it’s like I can feel something crawling in my
skin. And after I learned about this, I just feel the por-
phyrins flying around.
Suspecting porphyria cutanea tarda caused more health
problems than skin symptoms
Many participants suspected PCT caused health problems that
were not limited to the skin. They felt that porphyrins were
in their blood, and that genes and enzymes were involved,
which made them comment that things in the body were
connected. A variety of symptoms caused by PCT were pro-
posed and the participants showed a growing need to find
legitimate reasons for other health complaints. Maria
explained:
Perhaps it is a bit more complicated than what is
believed? That there are actually more symptoms? That
more things are connected to it? Because this is some-
thing that happens inside the body; that’s what I think,
that there might be.
Their suspicion was explained by the fact that the symptom
in question arose at the same time as their skin symptoms
appeared, and that other explanations had not been detected.
Participants learned that they had similar health problems after
speaking with other patients, which confirmed their suspi-
cions. Fatigue was explicitly discussed as being related to PCT,
but known acute porphyria symptoms, such as stomach pains
and muscle aches, were also attributed to PCT, both by partic-
ipants and sometimes by local health personnel. Participants
questioned why these symptoms were not recognized by med-
ical experts as being related to PCT and pointed to the need
for further research. However, the focus on what could be
attributed to PCT was so evident in the groups that some par-
ticipants commented that surely not everything could be
caused by the disease.
Theme 3: managing porphyria cutanea tarda – strategies
for prevention, treatment and controls
Preventive strategies: frequent controls, taking calculated
risks or doing nothing?
PCT was perceived as a chronic condition that patients needed
to manage for the remainder of their lives. For some, this
meant frequent controls and a vigilant lifestyle, with a focus
on eating habits, avoiding the sun and generally being careful.
For others, prevention involved taking blood samples and hav-
ing control intervals. Control intervals varied greatly, from
having ferritin levels never checked to having them checked
every 2 weeks, every month and twice a year. The merits of
this were debated by participants, and the more ‘experienced’
patients with PCT were asked for advice as to how often they
should be tested, which test should be done and who should
perform them. A few participants said they did nothing to
prevent PCT. As Lilly said, ‘I have a disease, but I’m not ill’.
Most took calculated risks and would enjoy alcohol, sun and
good food, but in moderation. They said they knew they
risked skin symptoms, but it was worth it. However, the sus-
picion that PCT caused other problems was more worrying.
Lilly said:
I think about it. But I choose to do it. And I think, like,
if I’m traveling to sunny places, if I happen to get a
blister, well that’s just. . . I have a blister, blood samples
and bloodletting. But what I might think about
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sometimes is, what does it do to other things in the
body? Right? I’m thinking cirrhosis. Kidney failure? I
mean, what if I defy this and perhaps avoid getting a
blister. But perhaps I got it because I didn’t take the
precautions I should. And I just used bloodletting as a
way to exceed my limitations. Do you understand what
I’m saying? Because I don’t want that, but this is some-
thing you don’t know a lot about yet. Right? What it
does to other organs? Because if it’s just a rash that can
be treated with draining blood? Well, then we can just
do whatever we want, can’t we?
Phlebotomy: simple and effective, but also demanding
and exhausting
Phlebotomy was viewed as very effective and provided rapid
relief from skin symptoms. Participants described the process
of letting blood as uncomplicated and easy, but, when they
were asked for further details, aspects that were more prob-
lematic emerged. There were discussions as to whether partici-
pants could lose important components of the blood that their
bodies needed. Some explained they would not drive a car or
ride a bicycle the same day, or they needed to take the day
off because they would get very tired. Several had stories of
fainting and of ‘going too low in blood values’, some to the
point that hospitalization was considered. Andrea dreaded hav-
ing phlebotomies:
Ah, I just felt that I was sweating and I was just about
to faint. So now when I am to let blood, it never used
to bother me, but now! Uh! Will they hit the spot or
not? So I start sweating already then. Because when the
needle is inside, and they start looking for the vein.
No. I’m finished. I dread it! Really!
Disagreement over the genetic testing of family members
Participants agreed that genetic testing was a choice that every
individual needed to make for themselves and that whatever
choice was made should be respected. There was disagreement
as to whether they would recommend testing of healthy fam-
ily members. For some, knowledge of genetic status was very
useful; for others, it was a cause of unnecessary worry. Several
pointed out that knowledge of PCT could be acquired without
genetic testing. Moreover, participants who did not worry
much about their own PCT were anxious about whether their
children and grandchildren had inherited the predisposing
gene. Exactly how genes were involved and how this would
affect their health seemed to be unclear and contributed to
making PCT more serious, as the following quote from Julia
illustrates:
I’ve told both my sisters, they know I have this. But
they weren’t interested in testing themselves and one of
my sisters, she has two grandchildren, she didn’t even
want them to know that I have this. This was in regards
to not wanting it to ruin their chances of having chil-
dren. It was their choice.
Discussion
This was a qualitative study and the transferability of results
must be viewed in relation to context and the sociocultural
setting.16 PCT is associated with haemochromatosis,17 hepatitis
and certain lifestyle factors, such as the intake of alcohol,
which should be considered when interpreting the results. In
the present study, all participants claimed to have normal or
restricted alcohol consumption, and hepatitis and alcohol as
predisposing factors therefore probably do not influence the
results or their interpretations. However, the psychosocial
stigma connected to hepatitis and alcohol abuse might have
prevented persons from volunteering to participate in the
focus group or limited their willingness to share this with the
group, a common problem in research based on voluntary
participation. The interviews were held in association with a
patient seminar, which might have heightened the partici-
pants’ awareness of PCT and thus affected their reflections.
This might have contributed to richer information, which is
desirable in qualitative studies. We argue that participants’
awareness does not compromise the validity of the study, but
rather reflects that human experiences cannot be reduced or
separated from their context.
The results showed a large variation in experiences, from
trivializing symptoms to very dramatic symptoms with a great
psychosocial impact on those afflicted. This is interesting in
view of the findings of Jong et al.,9 where PCT had a lower
impact on QoL, measured by the Dermatology Life Question-
naire Index, (DLQI), than other cutaneous porphyrias. That
the DLQI did not capture this variation in experiences is, per-
haps, not surprising. Health-related quality of life measures
are important for the assessment of disease severity, especially
in nonlife-threatening diseases such as skin diseases.18 How-
ever, they are especially aimed at generalization through a
focus on central tendencies, and condition-specific instruments
such as the DLQI are designed to be responsive to change.19
Both these aspects can be problematic considering that there
were only 12 people with PCT included in the study of Jong
et al.,9 and they were likely in clinical remission.9 However,
the qualitative design of the present study was aimed directly
at exploring health issues and providing substantive and rich
descriptions of the participants’ experiences with PCT. We
argue that focus groups based on interactive discussions might
be especially suited for capturing and elaborating the diversity
of experiences of participants in clinical remission.
Some participants with PCT mentioned itching to be a trou-
blesome symptom. Although pruritus is not well documented
in PCT, it has been reported previously.20 Itching is common
in many skin conditions and is likely to delay skin healing,
and is associated with reduced QoL, depression and sleep dis-
turbances.21–24 Consequently, this unsuspected finding war-
rants further investigation. To obtain more information on
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this topic, the Norwegian Porphyria Registry has introduced
this as a variable in the questionnaire sent to patients.
Based on the experiences of the participants in this study,
venesection was an acceptable first choice in treatment; how-
ever, some problematic aspects were introduced and, as low-
dose chloroquine is widely used,4 this might be preferable for
some patients. Our findings suggest that too vigilant a strategy
in the prevention of symptoms might lead to medicalization
rather than benefitting the patient. To the best of our knowl-
edge, there seems to be a lack of data regarding biochemical
and clinical relapse frequency. However, an annual assessment
of urinary porphyrin concentration and iron metabolism is
suggested in the detection of relapses.4 Although PCT has been
associated with changes in glucose metabolism,25 and an
increased risk of liver cancer,26 the mechanisms are unclear
and do not warrant the frequent check-ups (every 2 weeks or
every month) reported by some participants.27–29
PCT is generally defined as a skin disease but, aetiologically,
it is also a hepatic and metabolic disorder.5,30 Because the
symptoms are of a cutaneous nature, one would expect that
the patients experienced PCT as a skin condition. However,
participants in this study described a shift in focus from skin
to blood and began to perceive PCT as a chronic and systemic
disease. The tendency to attribute health problems to PCT was
striking. We are all ‘na€ıve psychologists’ seeking to explain
why events occur and to attribute causal explanations.31
According to the common sense model (CSM) of illness,32,33
there are five components of illness representations that help
people make sense of their symptoms: the identity or the label
given to the condition; the perceived cause of the condition;
the predictive understanding of how long the condition will
last; the individual’s beliefs about the consequences of the
condition; and whether the condition can be cured or con-
trolled.34 In this case, the identity of the condition is ‘por-
phyria’. Porphyrias are a group of diseases, and separating
PCT from other porphyrias can be difficult for both patients
and healthcare providers. Patients with PCT may perceive the
disease as being chronic and systemic because porphyrins,
enzymes, blood and genes are involved, and treatment consists
of bloodletting. This perception can, in turn, explain why par-
ticipants in this study attributed a number of their health
problems to PCT. The CSM uses the perception of the condi-
tion to guide which further actions are taken.34 Lilly stated
that medical experts do not fully understand the possible
long-term complications that this patient group might expect,
and therefore phlebotomies cannot be an ‘easy fix’ if symp-
toms arise. As Lilly commented, ‘if it’s just a rash that can be
treated with draining blood, well, then we can just do what-
ever we want to, can’t we?’ The genetic component of PCT
also seemed intriguing to the participants. A worry that a PCT
mutation might prevent anyone from having children, as was
the case in the family of one participant, emphasizes that the
perceived cause of the condition and the understanding of its
consequences should not be underestimated. When addressing
the issue of symptoms, consequences and controllability of
PCT in clinical consultation, it is therefore important to
recognize that the patient’s illness representation can influence
perception of risk and how they express and act upon this
information.
The results show that, at their worst, PCT symptoms can be
experienced as dramatic, and that a shift in focus from skin to
blood after establishing the diagnosis led to the perception of
PCT as a chronic, systemic disease that may cause a range
of unknown health problems. This suggests there is a need for
information and reassurance in clinical consultations, and as
long as patients are in biochemical remission and follow con-
trol guidelines,4 there is little reason for them to expect health
problems related to PCT. The effects of itching in PCT should
not be underestimated and was reported to be a severe prob-
lem for some participants. It is important that physicians and
healthcare personnel, as well as specialist centres that give
advice on PCT, are aware of the differences in how the
patients experience their disease, and that many of them expe-
rience it as much more than a skin disease, so that patient care
and disease management can be optimized.
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Porphyria cutanea tarda (PCT) requires long-term treat-
ment and follow-up, although many patients experience 
life-long remission. The aim of this cross-sectional postal 
survey was to describe and investigate the association 
between illness perception, health complaints, self-repor-
ted symptoms and distress in persons with PCT. The par-
ticipants perceived PCT as a chronic condition with high 
levels of personal and treatment control. Persons who 
reported active symptoms scored higher on perceived 
illness threat, total health complaints and psychological 
distress compared with those in remission or latent pha-
ses. However, a higher perception of illness threat and 
the total burden of health complaints were more closely 
associated with psychological distress than were percei-
ved PCT symptoms activity. This has implications for 
clinical consultation; dermatologists should be attentive 
to symptoms activity, but also recognize that patients in 
remission with a high perceived illness threat and multi-
ple health complaints might be especially vulnerable to 
psychological distress with regards to PCT. Key words: 
porphyria cutanea tarda; illness perception; psychological 
distress; subjective health complaints; psychosocial.
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Porphyria cutanea tarda (PCT) is the most common form 
of the porphyrias, a group of rare and mainly inherited 
metabolic diseases caused by reduced enzyme activity 
in the haem synthetic pathway (1). The prevalence is 
estimated at 1 in 10,000 (2), and approximately 50% of 
cases in Norway are hereditary, with a 10% penetrance 
(3). PCT symptoms usually present in late adulthood as 
skin fragility, blistering, milia, hypertrichosis and in-
creased pigmentation on sun-exposed areas, and can be 
triggered by iron overload, hepatic conditions, oestrogens 
and high alcohol intake. Treatment includes avoidance 
of precipitating factors, phlebotomy and/or administra-
tion of chloroquine (1, 4). Complete clinical remission 
can take up to 6–12 months (5, 6), but the prognosis is 
good, and lifelong remission is common. Guidelines sug-
gest that urinary porphyrin concentration, iron and liver 
function should be assessed annually in order to detect 
relapses (1, 4). Patients in biochemical remission have 
normal tolerance for sunlight.
Very little is known about the subjective experiences 
of PCT and, to our knowledge, only 2 previous research 
reports have focused on the psychosocial aspects of 
PCT. Jong et al. (7) found that PCT had less impact on 
quality of life (QoL) than did other cutaneous porphy-
rias and photodermatoses in general. However, only 
12 persons with PCT participated in the study, and the 
results should therefore be interpreted with caution. In 
contrast, a previous qualitative study found that PCT 
symptoms at their worst could be very dramatic and 
have a large psychosocial impact. The participants had a 
perception of the condition as systemic and chronic, and 
had a tendency to attribute a range of health problems 
to PCT. There were also reports of over-treatment, and 
frequent controls for patients in long-term remission 
(8). PCT patients are a heterogeneous group, compri-
sing persons with active symptoms, those in remission 
and asymptomatic mutation carriers (latent PCT), and 
they require various degrees of treatment and long-term 
follow-up. To optimize patient care it is, therefore, 
important to expand our understanding of how PCT is 
perceived and experienced by the patients themselves.
The aims of the present study were: (i) to describe 
and compare illness perception, self-reported health 
complaints and psychological distress in persons with 
various activity of PCT; and (ii) to examine the asso-
ciations between illness perception, self-reported health 
complaints, PCT symptoms, and psychological distress.
PATIENTS AND METHODS
Design
A cross-sectional survey comprising a battery of self-evaluative 
questionnaires was posted to all persons older than 18 years with 
PCT registered at the Norwegian Porphyria Centre (NAPOS). The 
study was approved by the Norwegian Regional Ethics Commit-
tee (2010/1140) and complies with the Declaration of Helsinki.
Sample and recruitment
NAPOS conducts nationwide diagnostics based on biochemical 
and DNA analysis in addition to predictive genetic testing. Almost 
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all persons with a known porphyria diagnosis in Norway are regis-
tered at NAPOS. Participants were recruited by NAPOS in May 
2010. Follow-up reminders were sent to non-responders in June 
and October the same year. Diagnosis was based on analysis of 
scanning and uroporphyrogen decarboxylase (UROD) DNA ana-
lysis according to established criteria (9). “Sporadic” PCT patients, 
for whom porphyria analysis had not been performed in the past 10 
years, were excluded from the study, based on the assumption that 
they had not experienced any PCT symptoms in the past 10 years.
Participants were categorized as having active PCT (porphyria 
symptoms in the day or week of the survey), PCT in remission 
(previous symptoms, but not at present) or latent PCT (mutation 
carriers who had never experienced PCT symptoms). Categoriza-
tion was based on self-reports and was assessed by the following 
question in the questionnaire: “Have you had any porphyria-rela-
ted complaints/symptoms?” followed by the answer categories: 
1, never; 2, previously; and 3, have today/this week.
Measures
Socio-demographic characteristics. The socio-demographic 
variables included sex, age, work status, educational level, 
cohabitation status and having children. 
Patient-reported outcome measures
Illness perception. The Brief Illness Perception Questionnaire 
(BIPQ) (10, 11) assesses the illness representations as adapted 
from the common sense model of Leventhal et al. (12) and has 
satisfactory validity and reliability. The questionnaire comprises 
8 items measuring different dimensions of illness perception: con-
sequences, timeline, personal control, treatment control, identity 
concern, emotions and coherence (illness comprehensibility). 
Identity refers to the symptoms a person views as part of the di-
sease. Responses are measured on a 0–10-point scale. An overall 
score was computed by summing across the 8 items. Higher scores 
Self-reported health complaints. The Subjective Health Com-
plaints (SHC) inventory measures self-reported health com-
plaints during the past 30 days on a 0–3 point Likert scale and 
without mapping the diagnosis or symptom attributions. The 
instrument is a 29-item scoring system that is categorized into 
5 factors: musculoskeletal, pseudoneurology, gastrointestinal, 
allergy, and influenza complaints (14, 15). The instrument has 
satisfactory reliability and validity (15). In the present study, 
only the mean total sum score was assessed.
Porphyria-related psychological distress. The Impact of Events 
-
instance, porphyria. The responses are measured on 2 subscales: 
intrusion and avoidance. Intrusion is characterized by unbidden 
thoughts and strong waves of feelings, and avoidance includes 
denial of the meanings and consequences of the event. The scale 
comprises 15 items: 7 on intrusion and 8 on avoidance. The 
responses are assessed on a 0–5-point Likert scale. The psycho-
metric properties have been found to be satisfactory (16, 17). 
Statistical analysis
Statistical analyses were performed using IBM SPSS Statistics 
Version 22.0 (Armonk, NY, USA). Most analyses were based 
on the 3 subgroups: active, remission and latent PCT. If more 
than 50% of the items were missing, the sum scores were not 
calculated for the IES subscales and the SHC inventory total 
(15). When calculating the overall score on the BIPQ, items 3, 4 
and 7 were reversed according to the manual. If any items were 
missing on the BIPQ, the overall score was not calculated (13). 
Differences in socio-demographic variables were investigated 
2 test for independence for categorical variab-
les. Separate 1-way Welch analysis of variance (ANOVA) was 
used to determine whether the scores on the BIPQ, SHC and 
IES subscales differed between the 3 PCT subgroups. There 
were some outliers and non-normality. As a sensitivity test we 
used a Kruskal–Wallis non-parametric test, which identified the 
same significant outcome measures as the ANOVA. 
To investigate the associations between illness perceptions, 
self-reported health complaints and porphyria-related psycho-
logical distress, 2 separate multiple linear regression analyses 
were conducted. The IES subscales intrusion and avoidance 
were the dependent variables and age, sex, SHC inventory total 
score, BIPQ total score and perceived PCT symptoms were 
entered as the predictors in the models. PCT symptoms were 
dichotomized into present symptoms (active PCT) or not present 
symptoms (remission and latent PCT). Twenty and 27% of the 
participants scored a total of 0 on the intrusion and avoidance 
the assumption of normality, those participants scoring a total 
of 0 on the IES subscales were removed from the multiple linear 
regression analysis. This resulted in a total of 185 (IES intrusion 
subscale) and 168 (IES avoidance subscale) for the regression 
analysis. Those scoring 0 on the subscales were distributed as 
follows: intrusion: active symptoms, n = 6, not active symptoms, 
n = 51; avoidance: active symptoms, n = 7, not active symptoms, 
n = 61. The assumptions of linearity, independence of errors, 
homoscedasticity and extreme outliers were met. Violation of 
the assumption of normality of residuals was addressed through 
logarithmic transformation of the outcome measure variables.
To investigate the likelihood of scoring 0 or > 0 on the IES 
subscales, logistic regression analyses were performed, using 
the same predictors and dependent variables as were specified 
in the multiple linear regression analyses.
RESULTS
A total of 484 persons registered with PCT were sent 
a postal questionnaire, and 272 were returned (56%). 
Nine participants were excluded from further analysis 
because of a missing response to the question categori-
zing participants into having active PCT, PCT in remis-
sion or latent PCT. A total of 263 (54%) questionnaires 
were eligible for further analysis.
Socio-demographic characteristics
Of the 263 respondents, 57 reported having present 
active PCT, 172 had PCT in remission and 34 reported 
latent PCT. For the total sample, the mean age was 59 
phic differences were found between the groups with 
regards to sex, age, and occupational and educational 
status. The active PCT group had more men than wo-
men, and the latent group had considerably more wo-
men. The mean age was >10 years younger in the latent 
PCT group than in the remission and active groups. For 
occupational status, 70% of the latent group reported 
being employed compared with 33% of the active group. 
Higher percentages of the active and remission groups 
retired (Table I).
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Patient-reported outcome measures
The total sample scored > 8 on the timeline item on the 
BIPQ, indicating a high belief in the condition being 
perceived illness threat compared with the other PCT 
subgroups. They also had considerably higher mean 
scores on the identity item, meaning that they believed 
more symptoms were caused by PCT compared with 
remission and latent PCT. The total sample had a relati-
vely high perception of coherence and personal control. 
On the treatment control item, the total sample 
scored even higher; although the remission group 
scored highest.
mean score on total intensity and frequency of 
subjective health complaints compared with the 
remission and latent PCT subgroups. The active 
PCT group had a higher mean value on reported 
psychological distress (intrusion and avoidance) 
than the remission subgroup, which had a higher 
mean score than the latent group (Table II).
Associations between illness perception, health 
complaints, self-reported porphyria cutanea 
tarda symptoms and psychological distress
When investigating the associations between ill-
ness perception, health complaints, self-reported 
PCT symptoms and psychological distress, we 
found that illness perception and total score on 
associated with a higher score on the intrusive 
scale and that the total model explained 30% 
of the variance. The same predictors were also 
significantly associated with the avoidance 
score and explained 20% of the variance. The 
self-reported presence of PCT symptoms were not 
related to porphyria (Table III). This means that al-
though participants reporting active PCT scored higher 
on perceived illness threat, total health complaints and 
porphyria-related psychological distress, PCT symp-
psychological distress.
We used the same predictors to investigate the 
probability of scoring > 0 on the IES avoidance and 
Table I. Socio-demographic characteristics of the sample





n = 57 (22)
In remission 
 n = 172 (65)
Latent 
n = 34 (13)
Sex
  Male 121 (47) 34 (60) 78 (46) 9 (27)
  Female 141 (53) 23 (40) 93 (54) 25 (73) 0.01*
Age, years   59 (25–88) 61 (29–87) 60 (25–88) 49 (31–87) < 0.01*
Occupational status
  Working 117 (44) 19 (33) 74 (43) 24 (70)
  Retired 77 (30) 18 (32) 56 (33) 3 (9)
  Disability pension 54 (20) 14 (25) 36 (21) 4 (12)
  Other 15 (6) 6 (10) 6 (3) 3 (9)  < 0.01*
Educational status
  Secondary school 58 (23) 10 (18) 45 (27) 3 (8)
  High school 117 (45) 32 (56) 71 (42) 14 (41)
  College/university 84 (32) 15 (26) 52 (31) 17 (50) 0.03*
Cohabitation
  Living alone 66 (25) 16 (29) 43 (25) 7 (21)
  Cohabitant 196 (75) 40 (71) 129 (75) 27 (79) 0.70
Children  
  Yes 232 (89) 54 (96) 146 (85) 32 (94)
  No 30 (11) 2 (4) 26 (15) 2 (6) 0.51
*p-value < 0.05. For categorical variables, p 2 test for 
independence or Fisher’s exact test when expected cell frequencies were < 5. p-value 
calculated with one-way analysis of variance (ANOVA) for continuous variables (age). 
Tukey’s post-hoc
and remission groups, but between latent and both remission and active sub-groups.






PCT in remission 
Mean (95% CI)
Latent PCT 
Mean (95% CI) p-value
Brief Illness Perception Questionnaire (0–10) (n = 235–261) (n = 51–57) (n = 156–170) (n = 28–34)
  Consequences 3.2 (2.9–3.5) 4.9 (4.1–5.7) 2.9 (2.5–3.3) 1.6 (1.0–2.2) < 0.01*
  Timeline 8.1 (7.7–8.5) 8.8 (8.2–9.4) 8.0 (7.5–8.4) 7.3 (5.8–8.8) 0.05*
  Personal control 5.8 (5.5–6.2) 5.4 (4.7–6.2) 6.2 (5.7–6.6) 4.9 (3.4–6.3) 0.9
  Treatment control 7.5 (7.1–7.8) 7.6 (6.9–8.4) 7.7 (7.2–8.1) 6.1 (5.2–7.1) 0.02*
  Identity 2.9 (2.6–3.3) 5.8 (5.2–6.5) 2.6 (2.2–2.9) 0.2 (0.0–0.3) < 0.01*
  Concern 3.4 (3.0–3.7) 4.8 (4.0–5.6) 3.2 (2.8–3.6) 1.9 (1.2–2.7) < 0.01*
  Coherence 5.6 (5.2–6.0) 5.9 (5.2–6.6) 5.7 (5.2–6.1) 4.7 (3.7–5.7) 0.12
  Emotional response 2.9 (2.5–3.2) 4.4 (3.6–5.3) 2.7 (2.3–3.0) 1.3 (0.7–1.9) < 0.01*
  Overall score 31.5 (29.9–33.2) 39.6 (35.8–43.4) 29.7 (27.9–31.5) 27.2 (23.3–31.1) < 0.01* 0.67
Subjective health complaints (n = 255) (n = 56) (n = 166) (n = 33)
  Total sum score 15.1 (13.6–16.7) 20.5 (16.7–24.2) 14.1 (12.4–15.8) 10.7 (7.7–13.7) < 0.1* 0.88
Impact of Events Scale (n = 258) (n = 57) (n = 169) (n = 32)
  Intrusion (0–35) 7.0 (6.0–7.9) 11.7 (9.1–14.3) 6.1 (5.1–7.1) 3.0 (1.6–4.4) < 0.01* 0.93
  Avoidance (0–40) 7.2 (6.2–8.1) 12.1 (9.5–14.7) 6.1 (5.1–7.1) 4.3 (2.2–6.4) < 0.01* 0.85
Score above 0 on IES (n = 206/189) (n = 51/50) (n = 136/120) (n = 19)
  Intrusion 8.7 (7.7–9.7) 13.1 (10.5–15.8) 7.6 (6.5–8.6) 5.1 (3.1–7.0) < 0.01*
  Avoidance 9.8 (8.7–10.9) 13.8 (11.1–16.4) 8.6 (7.5–9.7) 7.3 (4.4–10.1) < 0.01*
p-values for differences between means calculated using the Welch analysis of variance (ANOVA). *p
Acta Derm Venereol 96
677Illness perception and psychological distress in PCT
intrusion scales. Logistic regression analysis produced 
on total illness perception and more self-reported health 
> 0 on porphyria-related psychological distress.
DISCUSSION
The current study found a trend towards higher percei-
ved illness threat, more self-reported health complaints 
and more porphyria-related psychological distress in 
participants reporting active PCT compared with those 
reporting latent PCT or PCT in remission. However, 
the regression analysis did not support an association 
between PCT symptoms and higher scores on por-
phyria-related distress. By contrast, perceived illness 
threat and total health complaints were associated with 
greater porphyria-related distress. 
reported symptoms activity, was associated with 
porphyria-related distress suggests that, although PCT 
symptoms can be dramatic, PCT in remission can also 
be challenging for patients. Exactly what it is that makes 
some patients view PCT as a threatening disease cannot 
be answered by the present study. In view of the results 
showing that total health complaints are associated with 
PCT-distress, and that our previous study (8) showed 
from other conditions, a possible explanation might be 
that health complaints other than skin symptoms are also 
thought to be caused by PCT, and this is contributing to 
patients reporting higher psychological distress. Others 
have shown that the perception of disease is associated 
with psychological distress and QoL in dermatological 
disorders (18–20), and despite the diverse aetiology, 
photodermatosis (21) can have a major impact on QoL 
(7), psychological well-being and lifestyle (22), which 
suggests that the management of photosensitivity di-
sorders requires a biopsychosocial approach (18, 23) 
and that further studies are warranted investigating how 
PCT in both active and remission phases impacts QoL.
using focus groups (8), we found an overall high belief 
in the condition being chronic. This can be viewed as 
positive, in that it might increase compliance with the 
guidelines for control and preventive measures. Annual 
assessment of urinary porphyrin excretion, iron meta-
bolism and liver function are recommended (1). On the 
other hand, many patients with PCT are expected to 
experience life-long remission, and a high degree of per-
ceived chronicity and illness threat can entail an ethically 
challenging situation with a potential for medicalization 
of this group. Our previous study found evidence of over-
treatment; for example, frequent blood samples (every 
2 weeks and every month) in patients in remission (8). 
 
on total self-reported health complaints compared with 
the remission and latent PCT groups. Various hepatic 
conditions, haemochromatosis and lifestyle factors, such 
as high alcohol intake and smoking, are associated with 
active PCT (1, 4, 24) and might contribute to explaining 
that PCT is associated with other diseases may also have 
impacted on illness perception. Although data about this 
(i.e. alcoholism, hepatitis, etc.) was not investigated in 
the present study, the illness perception measurement 
the perception of PCT independent of other conditions. 
The socio-demographic differences between the PCT 
groups might also explain some of the observed dif-
ferences. Although there were more men than women 
in the active PCT group, women are generally known 
to report more substantial health complaints (25). An 
alternative explanation is that attribution of health 
complaints to PCT could have resulted in a “false” 
participants reported experiencing PCT as a systemic 
disease suspected to cause a range of health complaints 
higher on the identity item, indicating that this group 
attributed more symptoms to PCT.
Whether or not PCT is a distress-causing life-event, is 
PCT could certainly have a large negative psychosocial 
impact for some (8). In the present study, we did not 
use individual cut-off values to differentiate between 
distress and no distress, but rather tried to identify the 
factors associated with higher distress scores. Individual 
scores > 9 on the IES subscales have been used as an in-
dication of distress of a moderate character (26). Others 
a stressful event (27). Although these cut-off values 
are intended for assessment on an individual level, it is 
interesting to note that, as a group, those reporting active 
Table III. Multiple linear regression analysis with Impact of Events 
Score (IES) as the outcome measure
Variable
Intrusion (n = 185) Avoidance (n = 168)
B 95% CI p-value B 95% CI p-value
Constant 2.25 1.14–4.57 0.02 2.37 1.12–5.01 0.02
Age 0.99 0.98–1.00 0.11 1.00 0.99–1.01 0.87
Sex 1.09 0.86–1.34 0.44 1.13 0.86–1.47 0.38
SHC total 1.02 1.01–1.03 < 0.01* 1.02 1.01–1.04 < 0.01*
BIPQ total 1.03 1.01–1.04 < 0.01* 1.01 1.00–1.32 0.04*
PCT symptoms 1.24 0.92–1.68 0.15 1.31 0.94–1.81 0.11
Adjusted R2 0.30 0.20
*p p < 0.001). Analysis was performed 
(CI) presented in the table were back-transformed to the original units 
of measure. Participants scoring 0 on the IES subscales (Intrusion n = 57 
and Avoidance n = 68) were removed from the regression analysis. SHC: 
Subjective Health Complaints; BIPQ: Brief Illness Perception Questionnaire.
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PCT had a mean score on the intrusion and avoidance 
subscales in the “moderate distress” category. 
-
ted relatively high scores on coherence (understanding 
of the condition) and personal control. A high belief in 
treatment control was also reported, and the remission 
group reported the greatest belief in treatment, which in-
dicates that they experienced their treatment as adequate 
Compared with the personal control scores in those with 
contact dermatitis (mean 3.5) (19), the PCT patients had 
a greater belief in their own control of the condition.
in remission, and latent PCT was based on self-reported 
at exploring the subjective experiences of the participants 
and their own interpretation of their situation with regards 
evaluation of symptoms could have strengthened the 
study. A response rate of 54% is somewhat low and can 
be viewed as a limitation in terms of representability. 
In the present study, PCT was perceived as a chronic 
condition with a high degree of treatment control. Alt-
hough persons reporting active PCT had more health 
complaints and perceived PCT as more threatening 
compared with those reporting latent PCT or PCT in 
remission, psychological distress was more closely as-
sociated with a higher perception of illness threat and 
the total burden of health complaints than were percei-
ved PCT symptoms. This has implications for clinical 
consultations with this patient group. It seems evident 
that PCT patients need clear and concise information 
and guidance with regards to what health complaints 
are caused by PCT.
ACKNOWLEDGEMENTS
This study was funded by research grants from the Western 
Norwegian Regional Health Authorities. The authors would 
like to thank Karl Ove Hufthammer for valuable assistance 
with statistical analyses, and Egil Støle and Jørild Haugen for 
extensive assistance in recruitment of participants to the study.
REFERENCES 
1. Puy H, Gouya L, Deybach JC. Porphyrias. Lancet 2010; 
375: 924–937.
2. Mykletun M, Aarsand AK, Stole E, Villanger JH, Tollanes 
MC, Baravelli C, et al. Porphyrias in Norway. Tidsskr Nor 
Laegeforen 2014; 134: 831–835.
3. Aarsand AK, Boman H, Sandberg S. Familial and sporadic 
porphyria cutanea tarda: characterization and diagnostic 
strategies. Clin Chem 2009; 55: 795–803.
4. Kauppinen R. Porphyrias. Lancet 2005; 365: 241–252.
5. Frank J, Poblete-Gutierrez P. Porphyria cutanea tarda – 
when skin meets liver. Best Pract Res Cl Ga 2010; 24: 
735–745.
6. Sarkany RP. The management of porphyria cutanea tarda. 
Clin Exp Dermatol 2001; 26: 225–232.
7. Jong CT, Finlay AY, Pearse AD, Kerr AC, Ferguson J, 
Benton EC, et al. The quality of life of 790 patients with 
photodermatoses. Br J Dermatol 2008; 159: 192–197.
8. Andersen J, Gjengedal E, Sandberg S, Raheim M. A skin 
disease, a blood disease or something in between? An ex-
ploratory focus group study of patients’ experiences with 
porphyria cutanea tarda. Br J Dermatol 2015; 172: 223–229. 
9. Badminton MN, Whatley SD, Deacon AC, Elder GH. The 
porphyrias and other disorders of porphyrin metabolism. 
In: Burtis CA, Ashwood ER, Bruns DE, editors. Clinical 
chemistry and molecular diagnostics. 5th edn. New York: 
Elsevier Saunders; 2012. p. 1031–1054.
10. Broadbent E, Petrie KJ, Main J, Weinman J. The Brief 
Illness Perception Questionnaire. J Psychosom Res 2006; 
60: 631–637.
11. Broadbent E. BIPQ Norwegian version http://www.uib.no/
ipq/html/citing.html. [accessed 03 Feb 2015]. Available 
from: http://www.uib.no/ipq/html/citing.html.
12. Leventhal H, Nerenz DR, Steele DJ. Illness representations 
and coping with health threats. Handbook of psychology 
and health IV. NJ Erlbaum: Hillsdale; 1984. p. 219–252.
13. Broadbent E. The Brief Illness Perception Questionnaire 
Scoring instructions http://uib.no./ipq. [accessed 03 Feb 
2015]. Available from: http://uib.no./ipq.
14. Eriksen HR, Ihlebaek C. Subjective health complaints. 
Scand J Psychol 2002; 43: 101–103.
15. Eriksen HR, Ihlebaek C, Ursin H. A scoring system for 
subjective health complaints (SHC). Scand J Public Health 
1999; 27: 63–72.
16. Sundin EC, Horowitz MJ. Impact of event scale: psycho-
metric properties. Br J Psychiat 2002; 180: 205–209.
17. Sundin EC, Horowitz MJ. Horowitz’s impact of event scale 
evaluation of 20 years of use. Psychosom Med 2003; 65: 
870–876.
18. Richards HL, Ling TC, Evangelou G, Brooke RC, Huber 
K, Gibbs NK, et al. Psychologic distress in polymorphous 
light eruption and its relationship to patients’ beliefs about 
their condition. J Am Acad Dermatol 2007;56: 426–431.
19. Benyamini Y, Goner-Shilo D, Lazarov A. Illness percep-
tion and quality of life in patients with contact dermatitis. 
Contact Dermatitis 2012; 67: 193–199.
20. Cartwright T, Endean N, Porter A. Illness perceptions, 
coping and quality of life in patients with alopecia. Br J 
Dermatol 2009; 160: 1034–1039.
21. Bylaite M, Grigaitiene J, Lapinskaite GS. Photodermatoses: 
2009; 161 Suppl 3: 61–68.
22. Stafford R, Farrar MD, Kift R, Durkin MT, Berry JL, 
Webb AR, et al. The impact of photosensitivity disorders 
on aspects of lifestyle. Br J Dermatol 2010; 163: 817–822.
23. Rizwan M, Reddick CL, Bundy C, Unsworth R, Richards 
HL, Rhodes LE. Photodermatoses: environmentally indu-
ced conditions with high psychological impact. Photochem 
Photobio Sci 2013; 12: 182–189.
24. Darwich E, To-Figueras J, Molina-Lopez RA, Deulofeu R, 
Olbina G, Westerman M, et al. Increased serum hepcidin 
levels in patients with porphyria cutanea tarda. J Eur Acad 
Dermatol 2013; 27: e68–74.
25. Ihlebaek C, Eriksen HR, Ursin H. Prevalence of subjective 
health complaints (SHC) in Norway. Scand J Public Health 
2002; 30: 20–29.
26. Joseph S. Psychometric evaluation of Horowitz’s Impact of 
Event Scale: a review. J Trauma Stress 2000; 13: 101–113.
27. Thewes B, Meiser B, Hickie IB. Psychometric properties 
of the Impact of Event Scale amongst women at increased 
risk for hereditary breast cancer. Psychooncology 2001; 
10: 459–468.
Acta Derm Venereol 96
APPENDIX I 
INTERVJUGUIDE FOKUS 105 min = 1 time 45 min.  
A. ”Kaffepause” (10 min) Ønske velkommen til fokusgruppeintervju (10 min) 
- Presentere moderator og co moderator, og informere om rollene 
- Si noe om ”spilleregler” for fokusgruppeintervjuet, vi ønsker å lære av deltakerne, 
forteller personlige historier, interaksjon. Ingen rette og gale erfaringer 
- Oppfordre til taushetsplikt deltakerne imellom, vår taushetsplikt som forskere og 
helsepersonell.  
- Gi mulighet til å trekke seg fra intervjuet og studien 
- Informere om at gruppesamtalen er en enkeltstående hendelse. Ta kontakt ved behov. 
- Introduksjonsrunde: Navn, hvor er de fra? Ca diagnoseår og behandling? 
B. ”Tre tema for intervju” (70 min) 
1. ”Å være syk” 




- Den øvrige helsen? 
Hvordan reagerer andre? 
Hvilke begrensinger kan PCT medføre? 
2. Behandling 
Tanker rundt hva som forverrer og utløser symptomer? 
Tiltak i hverdagen? 
Blodtapping? Annen behandling? 
Helsepersonell og helsevesenets oppfølging? 
3. Fremtiden 
Gentest?  
Andre i familien? 
Hva forventer dere av symptomer i tiden fremover? 
Tanker om livssituasjon fremover? 
Forebygging og egeninnsats? 
C. Oppsummering og innspill (10 min) 
Co moderator gir en oppsummering av inntrykk fra gruppen 
Gruppen gir tilbakemelding 
D. Avslutning (5 min) 




Spørreskjema i forhold til helserelaterte utfordringer ved porphyria cutanea tarda 
(PCT) 
INFORMASJON OM DEG 
1. Kjønn:  Mann  Kvinne 
2. Alder:_______________år   
     
                 
3. Bosted: 
 Østlandet  Sørlandet  Vestlandet   
Midt-Norge  Nord-Norge 
4. Bosituasjon:   Bor alene  Bor med ektefelle/ samboer / partner  Annet bofellesskap (eks barn,  
         søsken, foreldre, andre) 
5. Har du barn? Nei        Ja  
6. Utdanning: 
 Grunnskole 
 3-årig videregående skole / yrkesskole el. l 
 Fullført høgskole / universitet 
  
7. Betrakter du deg hovedsakelig som: 
 Yrkesaktiv    Hjemmearbeidende med omsorg / husarbeid 
 Alderspensjonist    Skoleelev/student 
 Arbeidsledig    Trygdet/arbeidsufør 
 Annet 
     
8. Har du hatt porfyrirelaterte plager/symptomer?          Aldri hatt            Hatt tidligere        Har i dag / siste uke 
2
Brief Illness Perception Scale (BIPQ) 
  
Vennligst sett en ring rundt det tallet som best samsvarer med din mening om de følgende spørsmålene. 
1. Hvor mye påvirker porfyri livet ditt? 
0  1  2  3  4  5  6  7  8  9  10 
Ingen            Voldsom 
Påvirkning          påvirkning 
2.  Hvor lenge tror du at porfyrien  din vil vare?
0  1  2  3  4  5  6  7  8  9  10 
Svært kort tid           For alltid 
3.  Hvor mye kontroll føler du at du har over porfyrien din?
0  1  2  3  4  5  6  7  8  9  10 
Absolutt ingen           Svært stor 
kontroll            kontroll 
4.  Hvor mye mener du at behandlingen kan hjelpe mot porfyri?
0  1  2  3  4  5  6  7  8  9  10 
Ikke i det           Svært 
hele tatt            hjelpsom 
5.  Hvor mye opplever du symptomer fra porfyri? 
0  1  2  3  4  5  6  7  8  9  10 
Ingen symptomer       Mange 
i det hele tatt        alvorlige
      sympto  
6.  Hvor bekymret er du angående porfyri? 
0  1  2  3  4  5  6  7  8  9  10 
Ikke bekymret           Svært 
i det hele tatt           bekymret 
7.  Hvor godt føler du at du forstår porfyri? 
0  1  2  3  4  5  6  7  8  9  10 
Forstår ikke i det          Forstår 
hele tatt            svært godt 
8.  Hvor mye påvirker porfyri deg følelsesmessig? (dvs gjør den deg sint, redd, urolig eller 
deprimert?)
0  1  2  3  4  5  6  7  8  9  10 
Ikke påvirket i det          Svært 
hele tatt følelsesmessig         følelsesmessig 
påvirket 
9.  Vennligst skriv ned i rekkefølge de tre viktigste faktorene som du tror forårsaket porfyrien din. 





Impact of Events Scale (IES) 
Sett ring rundt det svaralternativet som passer best 
I høy Ganske  Middels Noe Litt  Aldri  
grad  mye   
    
1. Jeg har hatt perioder med sterke følelser  
omkring porfyri.. ........................................................  1 2 3 4 5 6  
2.  Ting jeg har sett og hørt minnet meg  
plutselig om porfyri... .................................................  1 2 3 4 5 6 
3.  Tanker om porfyri har trengt seg på  
også når jeg ikke har villet... ......................................  1 2 3 4 5 6  
4.  Bilder av porfyri har plutselig dukket  
opp i tankene mine.... .................................................  1 2 3 4 5 6  
5.  Enhver påminnelse har gjennopplivet 
 følelser knyttet til porfyri. .........................................  1 2 3 4 5 6  
6.  Jeg har hatt vanskelig for å sove på grunn  
av tanker og bilder om porfyri. ..................................  1 2 3 4 5 6 
7.  Jeg har vonde drømmer om porfyri.... ...................  1 2 3 4 5 6  
8.  Jeg vet mange uforløste følelser er der,  
men jeg har skjøvet dem bort... ..................................  1 2 3 4 5 6  
9.  Jeg har ikke tillatt meg å bli følelsesmessig berørt  
når jeg tenker på porfyri eller blir minnet om den......  1 2 3 4 5 6 
10.  Jeg har ønsket å bli kvitt minner om porfyri.... ...  1 2 3 4 5 6  
11.  Jeg har forsøkt å la være å snakke om porfyri.....  1 2 3 4 5 6  
12.  Jeg har opplevd det uvirkelig, som porfyri  
ikke har hendt eller ikke var virkelig. ........................  1 2 3 4 5 6  
13.  Jeg har holdt meg unna ting eller situasjoner 
som kan minne meg om porfyri.. ...............................  1 2 3 4 5 6 
14.  Mine følelser om porfyri er nærmest  
lammende......... ..........................................................  1 2 3 4 5 6  
15.  Jeg har ikke tillatt meg selv å ha tanker om  
porfyri. .......................................................................  1 2 3 4 5 6  
4
Subjective health complaints inventory (SHC)  
Helseproblemer siste 30 døgn 
NB! Det er viktig at du fyller ut både hvor plaget du har vært, og omtrent antall dager du har vært plaget siste tretti døgn. 
Nedenfor nevnes noen alminnelige helseproblemer 












1. Forkjølelse, influensa .................................  0 1 2 3 …………. 
2. Hoste, bronkitt ............................................  0 1 2 3 …………. 
3. Astma .........................................................  0 1 2 3 …………. 
4. Hodepine ....................................................  0 1 2 3 …………. 
5. Nakkesmerter .............................................  0 1 2 3 …………. 
6. Smerter øverst i ryggen ..............................  0 1 2 3 …………. 
7. Smerter i korsrygg ......................................  0 1 2 3 …………. 
8. Smerter i armer ...........................................  0 1 2 3 …………. 
9. Smerter i skuldre ........................................  0 1 2 3 …………. 
10. Migrene ......................................................  0 1 2 3 …………. 
11. Hjertebank, ekstraslag ................................  0 1 2 3 …………. 
12. Brystsmerter ...............................................  0 1 2 3 …………. 
13. Pustevansker ...............................................  0 1 2 3 …………. 
14. Smerter i føttene ved anstrengelser.............  0 1 2 3 …………. 
15. Sure oppstøt, «halsbrann» ..........................  0 1 2 3 …………. 
16. Sug eller svie i magen ................................  0 1 2 3 …………. 
17. Magekatarr, magesår ..................................  0 1 2 3 …………. 
18. Mageknip .................................................... 0 1 2 3 …………. 
19. «Luftplager» ...............................................  0 1 2 3 …………. 
20. Løs avføring, diaré .....................................  0 1 2 3 …………. 
21. Forstoppelse ...............................................  0 1 2 3 …………. 
22. Eksem .........................................................  0 1 2 3 …………. 
23. Allergi ........................................................  0 1 2 3 …………. 
24. Hetetokter ...................................................  0 1 2 3 …………. 
25. Søvnproblemer ...........................................  0 1 2 3 …………. 
26. Tretthet .......................................................  0 1 2 3 …………. 
27. Svimmelhet ................................................  0 1 2 3 …………. 
28. Angst ..........................................................  0 1 2 3 …………. 
29. Nedtrykt, depresjon ....................................  0 1 2 3 …………. 
   
APPENDIX III 
Search strategy 
Initial searches were performed on Medline and Web of Science, and repeated 
regularly by the author to find research related to the psychosocial and subjective 
experiences with AIP and PCT. 
A systematic search was conducted with the assistance of a trained librarian on 
January 7. 2016. The search was performed on the following electronic sources: 
Medline, Embase, PsychINFO and Cinahl. 

